Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 618 articles:
HTML format
Text format



Single Articles


    March 2017
  1. LOURENCO P, Silva S, Cunha F, Pereira J, et al
    Dipeptidyl peptidase-IV in chronic heart failure with reduced ejection fraction.
    Int J Cardiol. 2017 Mar 11. pii: S0167-5273(16)33739.
    PubMed     Text format     Abstract available


  2. PASCUAL-FIGAL DA, Ferrero-Gregori A, Gomez-Otero I, Vazquez R, et al
    Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.
    Int J Cardiol. 2017 Mar 9. pii: S0167-5273(17)30596.
    PubMed     Text format     Abstract available


  3. BONSU KO, Owusu IK, Buabeng KO, Reidpath DD, et al
    Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients.
    Int J Cardiol. 2017 Mar 6. pii: S0167-5273(17)31424.
    PubMed     Text format     Abstract available


  4. TSIMPLOULIS A, Sheriff HM, Lam PH, Dooley DJ, et al
    Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
    Int J Cardiol. 2017 Mar 1. pii: S0167-5273(17)31290.
    PubMed     Text format     Abstract available


    February 2017
  5. ABI KHALIL C, Sulaiman K, Singh R, Jayyousi A, et al
    BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: Findings from the Gulf aCute heArt failuRE (Gulf-CARE) registry.
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(16)34386.
    PubMed     Text format     Abstract available


  6. AKITA K, Kohno T, Kohsaka S, Shiraishi Y, et al
    Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31098.
    PubMed     Text format     Abstract available


  7. ALHABEEB W, Elasfar A, AlBackr H, AlShaer F, et al
    Clinical characteristics, management and outcomes of patients with chronic heart failure: Results from the heart function assessment registry trial in Saudi Arabia (HEARTS-chronic).
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31118.
    PubMed     Text format     Abstract available


  8. YAMADA S, Lo LW, Chou YH, Lin WL, et al
    Renal denervation regulates the atrial arrhythmogenic substrates through reverse structural remodeling in heart failure rabbit model.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31114.
    PubMed     Text format     Abstract available


  9. VAN BOVEN N, Akkerhuis KM, Anroedh SS, Rizopoulos D, et al
    Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31107.
    PubMed     Text format     Abstract available


  10. SZMIT S, Jurczak W, Zaucha JM, Dlugosz-Danecka M, et al
    Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31101.
    PubMed     Text format     Abstract available


  11. ANSELMINO M, Matta M, Bunch TJ, Fiala M, et al
    Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(16)33338.
    PubMed     Text format     Abstract available


  12. AMIN A, von Haehling S
    Updates in heart failure: Highlights from the Iranian Joint Cardiovascular Congress Tehran, Iran, 1-4 March 2016.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31117.
    PubMed     Text format    


  13. MAFFESSANTI F, Wanten J, Potse M, Regoli F, et al
    The relation between local repolarization and T-wave morphology in heart failure patients.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(16)34312.
    PubMed     Text format     Abstract available


  14. FRIGERIO M, Mazzali C, Paganoni AM, Ieva F, et al
    Trends in heart failure hospitalizations, patient characteristics, in-hospital and 1-year mortality: A population study, from 2000 to 2012 in Lombardy.
    Int J Cardiol. 2017 Feb 21. pii: S0167-5273(16)34743.
    PubMed     Text format     Abstract available


  15. KARLSTROM P, Johansson P, Dahlstrom U, Boman K, et al
    The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study.
    Int J Cardiol. 2017 Feb 17. pii: S0167-5273(16)33177.
    PubMed     Text format     Abstract available


  16. COWIE MR, Lopatin YM, Saldarriaga C, Fonseca C, et al
    The Optimize Heart Failure Care Program: Initial lessons from global implementation.
    Int J Cardiol. 2017 Feb 12. pii: S0167-5273(17)30746.
    PubMed     Text format     Abstract available


  17. DENFELD QE, Winters-Stone K, Mudd JO, Gelow JM, et al
    The prevalence of frailty in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Feb 10. pii: S0167-5273(16)32977.
    PubMed     Text format     Abstract available


  18. RODRIGUEZ-PASCUAL C, Paredes-Galan E, Ferrero-Martinez AI, Gonzalez-Guerrero JL, et al
    The frailty syndrome is associated with adverse health outcomes in very old patients with stable heart failure: A prospective study in six Spanish hospitals.
    Int J Cardiol. 2017 Feb 8. pii: S0167-5273(16)34474.
    PubMed     Text format     Abstract available


  19. OLIVIER A, Girerd N, Michel JB, Ketelslegers JM, et al
    Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Pos
    Int J Cardiol. 2017 Feb 8. pii: S0167-5273(16)32115.
    PubMed     Text format     Abstract available


    January 2017
  20. KHALID U, Wruck LM, Quibrera PM, Bozkurt B, et al
    BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Int J Cardiol. 2017 Jan 31. pii: S0167-5273(17)30599.
    PubMed     Text format     Abstract available


  21. ZHANG J, Wong KY, Clark AL, Cleland JG, et al
    Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling.
    Int J Cardiol. 2017 Jan 27. pii: S0167-5273(17)30557.
    PubMed     Text format     Abstract available


  22. SWEDBERG K, Bohm M, Borer JS, Ford I, et al
    Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al.
    Int J Cardiol. 2017 Jan 23. pii: S0167-5273(16)34108.
    PubMed     Text format    


  23. BOTTO GL, Padeletti L, Covino G, Pieragnoli P, et al
    Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)33105.
    PubMed     Text format     Abstract available


  24. NAGAO K, Tamura A, Morimoto T, Shimamura K, et al
    Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course.
    Int J Cardiol. 2017 Jan 15. pii: S0167-5273(16)33698.
    PubMed     Text format     Abstract available


  25. ZHANG X, Cheng HJ, Zhou P, Kitzman DW, et al
    Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.
    Int J Cardiol. 2017 Jan 10. pii: S0167-5273(16)33227.
    PubMed     Text format     Abstract available


  26. KISHIMOTO S, Kajikawa M, Maruhashi T, Iwamoto Y, et al
    Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(16)32405.
    PubMed     Text format     Abstract available


  27. ZYMLINSKI R, Sokolski M, Siwolowski P, Biegus J, et al
    Elevated troponin I level assessed by a new high-sensitive assay and the risk of poor outcomes in patients with acute heart failure.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30031.
    PubMed     Text format     Abstract available


  28. KONTOGEORGOS S, Thunstrom E, Johansson MC, Fu M, et al
    Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30080.
    PubMed     Text format     Abstract available


  29. MARTINEZ F, Martinez-Ibanez L, Pichler G, Ruiz A, et al
    Multimorbidity and acute heart failure in internal medicine.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30039.
    PubMed     Text format     Abstract available


  30. VON BIBRA H, Strohle A, St John Sutton M, Worm N, et al
    Dietary therapy in heart failure with preserved ejection fraction and/or left ventricular diastolic dysfunction in patients with metabolic syndrome.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30022.
    PubMed     Text format     Abstract available


  31. HARJOLA P, Boyd J, Tarvasmaki T, Mattila J, et al
    The impact of emergency medical services in acute heart failure.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(17)30036.
    PubMed     Text format     Abstract available


    December 2016
  32. YANG Y, Huang WL, Yang J, Yang J, et al
    5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure.
    Int J Cardiol. 2016 Dec 29. pii: S0167-5273(16)34194.
    PubMed     Text format    


  33. KORATALA A, Jain A, Kazory A
    Ultrafiltration does provide more efficient decongestion compared to conventional treatment for acute heart failure.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)34131.
    PubMed     Text format    


  34. LARSSON SC, Wallin A, Wolk A
    Contrasting association between alcohol consumption and risk of myocardial infarction and heart failure: Two prospective cohorts.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)33141.
    PubMed     Text format     Abstract available


  35. PEARSON MJ, Smart NA
    Effect of exercise training on endothelial function in heart failure patients: A systematic review meta-analysis.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)32418.
    PubMed     Text format     Abstract available


  36. CORREALE M, Carpagnano GE, Brunetti ND, Forte L, et al
    Respiratory drive in patients with chronic heart failure and central sleep apnea: Data from the Daunia Heart Failure Registry.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34823.
    PubMed     Text format    


  37. SANCHEZ-GIL J, Manzano L, Flather M, Formiga F, et al
    Combining heart rate and systolic blood pressure to improve risk stratification in older patients with heart failure: Findings from the RICA Registry.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34527.
    PubMed     Text format     Abstract available


  38. KATAOKA H
    Vascular expansion during worsening of heart failure: Effects on clinical features and its determinants.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34547.
    PubMed     Text format     Abstract available


  39. LIN YH, Kuo CC, Wu KK
    Reply to letter: "5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure".
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34776.
    PubMed     Text format    


  40. ASANO R, Kajimoto K, Oka T, Sugiura R, et al
    Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34539.
    PubMed     Text format     Abstract available


  41. XANTHOPOULOS A, Giamouzis G, Tryposkiadis K, Paraskevopoulou E, et al
    A simple score for early risk stratification in acute heart failure.
    Int J Cardiol. 2016 Dec 22. pii: S0167-5273(16)34584.
    PubMed     Text format     Abstract available


  42. LIN TY, Chen CY, Huang YB
    Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34589.
    PubMed     Text format     Abstract available


  43. IWAKAMI N, Nagai T, Furukawa TA, Sugano Y, et al
    Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34552.
    PubMed     Text format     Abstract available


  44. SEGUCHI O, Hisamatsu E, Nakano A, Nakajima S, et al
    Low partial pressure of end-tidal carbon dioxide predicts left ventricular assist device implantation in patients with advanced chronic heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34593.
    PubMed     Text format     Abstract available


  45. CHEN Y, Cai L, Du Z, Xu J, et al
    Dipstick proteinuria is a prognostic indicator of short-term mortality in patients with heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34587.
    PubMed     Text format     Abstract available


  46. IKEDA Y, Ishii S, Fujita T, Iida Y, et al
    Prognostic impact of intestinal wall thickening in hospitalized patients with heart failure.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34551.
    PubMed     Text format     Abstract available


  47. OKABE T, Yakushiji T, Kido T, Oyama Y, et al
    Relationship between worsening renal function and long-term cardiovascular mortality in heart failure patients.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34592.
    PubMed     Text format     Abstract available


  48. KOELL B, Zotter-Tufaro C, Duca F, Kammerlander AA, et al
    Fluid status and outcome in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34570.
    PubMed     Text format     Abstract available


  49. WANNAMETHEE SG, Whincup PH, Papacosta O, Lennon L, et al
    Associations between blood coagulation markers, NT-proBNP and risk of incident heart failure in older men: The British Regional Heart Study.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34544.
    PubMed     Text format     Abstract available


  50. FONSECA R, Otahal P, Galligan J, Neilson S, et al
    Association of survival time with transthoracic echocardiography in stable patients with heart failure: Is routine follow-up ever appropriate?
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34529.
    PubMed     Text format     Abstract available


  51. OMAR HR, Guglin M
    Acute systolic heart failure with normal admission BNP: clinical features and outcomes.
    Int J Cardiol. 2016 Dec 20. pii: S0167-5273(16)34558.
    PubMed     Text format     Abstract available


  52. AGRA BERMEJO RM, Gonzalez Ferreiro R, Varela Roman A, Gomez Otero I, et al
    Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure.
    Int J Cardiol. 2016 Dec 19. pii: S0167-5273(16)34557.
    PubMed     Text format     Abstract available


  53. HONDA S, Nagai T, Anzai T
    Reply to "delirium in heart failure".
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34253.
    PubMed     Text format    


    November 2016
  54. ASCHAUER S, Zotter-Tufaro C, Duca F, Kammerlander A, et al
    Modes of death in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016;228:422-426.
    PubMed     Text format     Abstract available


  55. AREVALO-LORIDO JC, Carretero-Gomez J, Manzano-Espinosa L
    Reply to the Letter to Editor "Hyposmolarity may be also associated with worse outcomes in patients with heart failure".
    Int J Cardiol. 2016 Nov 17. pii: S0167-5273(16)33930.
    PubMed     Text format    


  56. BERARDINI A, Biagini E, Saia F, Stolfo D, et al
    Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure?
    Int J Cardiol. 2016;228:191-197.
    PubMed     Text format     Abstract available


  57. SHEN Y, Du K
    Hyposmolarity may be also associated with worse outcomes in patients with heart failure.
    Int J Cardiol. 2016 Nov 12. pii: S0167-5273(16)32987.
    PubMed     Text format    


  58. OMAR HR, Guglin M
    Mitral annulus diameter is the main echocardiographic correlate of S3 gallop in acute heart failure.
    Int J Cardiol. 2016;228:834-836.
    PubMed     Text format    


  59. FUKUTA H, Goto T, Wakami K, Ohte N, et al
    The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies.
    Int J Cardiol. 2016;228:4-10.
    PubMed     Text format     Abstract available


  60. LEE YC, Chang CH, Dong YH, Lin JW, et al
    Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study.
    Int J Cardiol. 2016;228:1007-1014.
    PubMed     Text format     Abstract available


  61. MIZZACI CC, Porfirio GJ, Vilela AT, Guillhen JC, et al
    Ivabradine as adjuvant treatment for chronic heart failure.
    Int J Cardiol. 2016;227:43-50.
    PubMed     Text format     Abstract available


  62. MENG Y, Liu X, Liu J, Cheng X, et al
    A prospective study on the impact of heart rate control achieved with metoprolol on cardiac performance, motor function and quality of life in Chinese chronic heart failure patients.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33574.
    PubMed     Text format     Abstract available


  63. SINNING C, Kempf T, Schwarzl M, Lanfermann S, et al
    Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33567.
    PubMed     Text format     Abstract available


  64. ADACHI H, Katsuyama H, Yanai H
    The low dose (7.5mg/day) pioglitazone is beneficial to the improvement in metabolic parameters without weight gain and an increase of risk for heart failure.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33586.
    PubMed     Text format    


  65. ZHENG YR, Ye LF, Cen XJ, Lin JY, et al
    Low NT-proBNP levels: An early sign for the diagnosis of ischemic heart failure.
    Int J Cardiol. 2016;228:666-671.
    PubMed     Text format     Abstract available


  66. HAJDUSEK P, Kotrc M, Kautzner J, Melenovsky V, et al
    Heart rate response to exercise in heart failure patients: The prognostic role of metabolic-chronotropic relation and heart rate recovery.
    Int J Cardiol. 2016;228:588-593.
    PubMed     Text format     Abstract available


  67. ALAGIAKRISHNAN K, Mah D, Dyck JR, Senthilselvan A, et al
    Comparison of two commonly used clinical cognitive screening tests to diagnose mild cognitive impairment in heart failure with the golden standard European Consortium Criteria.
    Int J Cardiol. 2016;228:558-562.
    PubMed     Text format     Abstract available


  68. GOGGINS WB, Chan EY
    A study of the short-term associations between hospital admissions and mortality from heart failure and meteorological variables in Hong Kong: Weather and heart failure in Hong Kong.
    Int J Cardiol. 2016;228:537-542.
    PubMed     Text format     Abstract available


  69. AGRA RM, Varela-Roman A, Gonzalez-Ferreiro R, Vinuela JE, et al
    Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure.
    Int J Cardiol. 2016;228:488-494.
    PubMed     Text format     Abstract available


  70. MUNIBARI AN, Al-Motarreb A, Al-Sagheer N, Hadi HA, et al
    Clinical characteristics and outcomes of Yemeni patients with acute heart failure aged 50years or younger: Data from Gulf Acute Heart Failure Registry (Gulf CARE).
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)32093.
    PubMed     Text format     Abstract available


  71. AL-KHATEEB M, Qureshi WT, Odeh R, Ahmed AM, et al
    The impact of digoxin on mortality in patients with chronic systolic heart failure: A propensity-matched cohort study.
    Int J Cardiol. 2016;228:214-218.
    PubMed     Text format     Abstract available


  72. OTAKI Y, Watanabe T, Kinoshita D, Yokoyama M, et al
    Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
    Int J Cardiol. 2016;228:151-157.
    PubMed     Text format     Abstract available


  73. KULARATNA S, Byrnes J, Chan YK, Carrington MJ, et al
    Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions.
    Int J Cardiol. 2016;227:172-176.
    PubMed     Text format     Abstract available


  74. TSAI MY, Hu WL, Lin CC, Lee YC, et al
    Prescription pattern of Chinese herbal products for heart failure in Taiwan: A population-based study.
    Int J Cardiol. 2016;228:90-96.
    PubMed     Text format     Abstract available


  75. STRAUSS E, Supinski W, Radziemski A, Oszkinis G, et al
    Is hyperhomocysteinemia a causal factor for heart failure? The impact of the functional variants of MTHFR and PON1 on ischemic and non-ischemic etiology.
    Int J Cardiol. 2016;228:37-44.
    PubMed     Text format     Abstract available


  76. KWOK CS, Wong CW, Rushton CA, Ahmed F, et al
    Ultrafiltration for acute decompensated cardiac failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;228:122-128.
    PubMed     Text format     Abstract available


  77. STOLLBERGER C, Schneider B
    Concerns about the ESC heart failure guidelines.
    Int J Cardiol. 2016;228:707-708.
    PubMed     Text format    


  78. USZKO-LENCER NH, Frankenstein L, Spruit MA, Maeder MT, et al
    Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33581.
    PubMed     Text format     Abstract available


  79. TAMARGO J, Rosano GM, Delpon E, Ruilope L, et al
    Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33583.
    PubMed     Text format     Abstract available


  80. JACOB J, Tost J, Miro O, Herrero P, et al
    Impact of chronic obstructive pulmonary disease on clinical course after an episode of acute heart failure. EAHFE-COPD study.
    Int J Cardiol. 2016 Nov 8. pii: S0167-5273(16)33443.
    PubMed     Text format     Abstract available


  81. HIRAKAWA K, Yamamuro M, Uemura T, Takashio S, et al
    Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis.
    Int J Cardiol. 2016;228:881-885.
    PubMed     Text format     Abstract available


  82. GIULIANO C, Karahalios A, Neil C, Allen J, et al
    The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure - A meta-analysis.
    Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33469.
    PubMed     Text format     Abstract available


  83. LAM PH, Dooley DJ, Inampudi C, Arundel C, et al
    Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.
    Int J Cardiol. 2016 Nov 4. pii: S0167-5273(16)33408.
    PubMed     Text format     Abstract available


  84. KAZORY A
    The lower risk of de novo heart failure associated with peritoneal dialysis; the timing does matter.
    Int J Cardiol. 2016 Nov 2. pii: S0167-5273(16)33043.
    PubMed     Text format    


  85. OLDENBURG O, Coats A
    CSA Is Not Beneficial Long Term in Heart Failure Patients with Reduced Ejection Fraction.
    Int J Cardiol. 2016 Nov 2. pii: S0167-5273(16)33404.
    PubMed     Text format     Abstract available


    October 2016
  86. ARIMURA T, Saku K, Kakino T, Nishikawa T, et al
    Intravenous electrical vagal nerve stimulation prior to coronary reperfusion in a canine ischemia-reperfusion model markedly reduces infarct size and prevents subsequent heart failure.
    Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33267.
    PubMed     Text format     Abstract available


  87. BRENNER S, Christa M, Berliner D, Deubner N, et al
    Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction.
    Int J Cardiol. 2016 Oct 28. pii: S0167-5273(16)33245.
    PubMed     Text format     Abstract available


  88. WANG IK, Lin CL, Sung FC
    Lower risk of de novo congestive heart failure in peritoneal dialysis patients compared with hemodialysis patients.
    Int J Cardiol. 2016 Oct 27. pii: S0167-5273(16)33116.
    PubMed     Text format    


  89. METRA M, Carubelli V, Ravera A, Stewart Coats AJ, et al
    Heart failure 2016: still more questions than answers.
    Int J Cardiol. 2016 Oct 26. pii: S0167-5273(16)33156.
    PubMed     Text format     Abstract available


  90. TOYODA S, Haruyama A, Inami S, Amano H, et al
    Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure.
    Int J Cardiol. 2016;226:71-76.
    PubMed     Text format     Abstract available


  91. CHENG S, Wang H, Lu M, Cui C, et al
    The value of CMR for determination of heart failure etiology: An unusual case with histology validation.
    Int J Cardiol. 2016;226:38-41.
    PubMed     Text format    


  92. SAVARESE G, Donal E, Hage C, Oger E, et al
    Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.
    Int J Cardiol. 2016;226:65-70.
    PubMed     Text format     Abstract available


  93. BOULOGNE M, Sadoune M, Launay JM, Baudet M, et al
    Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction.
    Int J Cardiol. 2016;226:53-59.
    PubMed     Text format     Abstract available


  94. CUI X, Zhou J, Jin X, Zhou J, et al
    Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents.
    Int J Cardiol. 2016 Oct 17. pii: S0167-5273(16)33012.
    PubMed     Text format     Abstract available


  95. STAFYLAS P, Farmakis D, Kourlaba G, Giamouzis G, et al
    The heart failure pandemic: The clinical and economic burden in Greece.
    Int J Cardiol. 2016 Oct 17. pii: S0167-5273(16)33013.
    PubMed     Text format     Abstract available


  96. ACANFORA D, Scicchitano P, Casucci G, Lanzillo B, et al
    Exercise training effects on elderly and middle-age patients with chronic heart failure after acute decompensation: A randomized, controlled trial.
    Int J Cardiol. 2016;225:313-323.
    PubMed     Text format     Abstract available


  97. REYNOLDS JO, Quick AP, Wang Q, Beavers DL, et al
    Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca2+ release.
    Int J Cardiol. 2016;225:371-380.
    PubMed     Text format     Abstract available


  98. CARUBELLI V, Cotter G, Davison B, Gishe J, et al
    In-hospital worsening heart failure in patients admitted for acute heart failure.
    Int J Cardiol. 2016;225:353-361.
    PubMed     Text format     Abstract available


  99. OMAR HR, Guglin M
    Community acquired versus hospital acquired hyponatremia in acute heart failure: Association with clinical characteristics and outcomes.
    Int J Cardiol. 2016;225:247-249.
    PubMed     Text format    


  100. SAITOH M, Dos Santos MR, Anker M, Anker SD, et al
    Neuromuscular electrical stimulation for muscle wasting in heart failure patients.
    Int J Cardiol. 2016;225:200-205.
    PubMed     Text format     Abstract available


    September 2016
  101. BERKVENS CP, Mommersteeg PM
    Letter to the editor: Is an ischemic etiology especially detrimental for women with heart failure?
    Int J Cardiol. 2016 Sep 30. pii: S0167-5273(16)32162.
    PubMed     Text format    


  102. MASUTANI S, Kuwata S, Kurishima C, Iwamoto Y, et al
    Ventricular-vascular dynamics in pediatric patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2016;225:306-312.
    PubMed     Text format     Abstract available


  103. BROWN LA, Boos CJ
    Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.
    Int J Cardiol. 2016 Sep 30. pii: S0167-5273(16)32512.
    PubMed     Text format     Abstract available


  104. BATLLE M, Campos B, Farrero M, Cardona M, et al
    Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP.
    Int J Cardiol. 2016;225:113-119.
    PubMed     Text format     Abstract available


  105. SALZANO A, Marra AM, Ferrara F, Arcopinto M, et al
    Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;225:1-3.
    PubMed     Text format    


  106. ROCHA A, Arbex FF, Alencar MC, Sperandio PA, et al
    Physiological and sensory consequences of exercise oscillatory ventilation in heart failure-COPD.
    Int J Cardiol. 2016;224:447-453.
    PubMed     Text format     Abstract available


  107. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Int J Cardiol. 2016;225:30-36.
    PubMed     Text format     Abstract available


  108. SIMIONIUC A, Carluccio E, Ghio S, Rossi A, et al
    Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients.
    Int J Cardiol. 2016;224:416-423.
    PubMed     Text format     Abstract available


  109. GHOSH RK, Ball S, Prasad V, Gupta A, et al
    Depression in heart failure: Intricate relationship, pathophysiology and most updated evidence of interventions from recent clinical studies.
    Int J Cardiol. 2016;224:170-177.
    PubMed     Text format     Abstract available


  110. TANAKA S, Kamiya K, Masuda T, Hamazaki N, et al
    Low ankle brachial index is associated with the magnitude of impaired walking endurance in patients with heart failure.
    Int J Cardiol. 2016;224:400-405.
    PubMed     Text format     Abstract available


  111. MINAMI Y, Kajimoto K, Sato N, Hagiwara N, et al
    End-stage renal disease patients on chronic maintenance hemodialysis in a hospitalized acute heart failure cohort: Prevalence, clinical characteristics, therapeutic options, and mortality.
    Int J Cardiol. 2016;224:267-270.
    PubMed     Text format    


  112. CHUGH Y, Faillace RT
    The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
    Int J Cardiol. 2016;224:431-436.
    PubMed     Text format     Abstract available


  113. VAN DEN BERGE JC, Akkerhuis MK, Constantinescu AA, Kors JA, et al
    Temporal trends in long-term mortality of patients with acute heart failure: Data from 1985-2008.
    Int J Cardiol. 2016;224:456-460.
    PubMed     Text format     Abstract available


  114. CULIC V, Busic Z, Busic M
    Circulating sex hormones, alcohol consumption and echocardiographic parameters of cardiac function in men with heart failure.
    Int J Cardiol. 2016;224:245-251.
    PubMed     Text format    


  115. HOLLINGWORTH W, Biswas M, Maishman RL, Dayer MJ, et al
    The healthcare costs of heart failure during the last five years of life: A retrospective cohort study.
    Int J Cardiol. 2016;224:132-138.
    PubMed     Text format     Abstract available


  116. LAINSCAK M, Vitale C, Seferovic P, Spoletini I, et al
    Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure.
    Int J Cardiol. 2016;224:191-198.
    PubMed     Text format     Abstract available


  117. KAMIYA M, Kamiya M, Tsuzuki M, Tanaka T, et al
    Prevention of re-hospitalization by home-based intervention and adaptive servo-ventilation therapy in a patient who experienced repeated hospitalization for decompensated heart failure.
    Int J Cardiol. 2016;224:96-98.
    PubMed     Text format    


  118. VEGTER EL, Schmitter D, Hagemeijer Y, Ovchinnikova ES, et al
    Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.
    Int J Cardiol. 2016;224:231-239.
    PubMed     Text format     Abstract available


  119. MASSON S, Barlera S, Colotta F, Magnoli M, et al
    A low plasma 1,25(OH)2 vitamin D/PTH (1-84) ratio predicts worsening of renal function in patients with chronic heart failure.
    Int J Cardiol. 2016;224:220-225.
    PubMed     Text format     Abstract available


  120. PALAZZUOLI A, Testani JM, Ruocco G, Pellegrini M, et al
    Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
    Int J Cardiol. 2016;224:213-219.
    PubMed     Text format     Abstract available


  121. HICKEY A, Suna J, Marquart L, Denaro C, et al
    Improving medication titration in heart failure by embedding a structured medication titration plan.
    Int J Cardiol. 2016;224:99-106.
    PubMed     Text format     Abstract available


    August 2016
  122. ARAMBULA-GARZA E, Castillo-Martinez L, Gonzalez-Islas D, Orea-Tejeda A, et al
    Association of cardiac cachexia and atrial fibrillation in heart failure patients.
    Int J Cardiol. 2016;223:863-866.
    PubMed     Text format     Abstract available


  123. GAJANANA D, Shah M, Junpapart P, Romero-Corral A, et al
    Mortality in systolic heart failure revisited: Ischemic versus non-ischemic cardiomyopathy.
    Int J Cardiol. 2016;224:15-17.
    PubMed     Text format    


  124. RUSSO G, Cioffi G, Pulignano G, Barbati G, et al
    Reasons why patients suffering from chronic heart failure at very low risk for mortality die.
    Int J Cardiol. 2016;223:947-952.
    PubMed     Text format     Abstract available


  125. FAYSSOIL A
    Which place for ivabradine in Duchenne muscular dystrophy with heart failure?
    Int J Cardiol. 2016;223:768-769.
    PubMed     Text format    


  126. HUIS IN 'T VELD AE, Van Vliet AG, Spruijt OA, Handoko ML, et al
    CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension.
    Int J Cardiol. 2016;223:723-728.
    PubMed     Text format     Abstract available


  127. NUNEZ J, Teruel A, Quinones-Torrelo C, Garcia-Blas S, et al
    Continuous ambulatory peritoneal dialysis as a promising therapy for light chain amyloidosis with congestive heart failure.
    Int J Cardiol. 2016;223:807-809.
    PubMed     Text format    


  128. DEMISSEI BG, Postmus D, Liu LC, Cleland JG, et al
    Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial.
    Int J Cardiol. 2016;223:967-975.
    PubMed     Text format     Abstract available


  129. KAWADA T
    Risk of hemodialysis against peritoneal dialysis for chronic heart failure in patients with end-stage renal disease.
    Int J Cardiol. 2016;223:360.
    PubMed     Text format    


  130. BAKIR M, Nelson MD, Jones E, Li Q, et al
    Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.
    Int J Cardiol. 2016;223:936-939.
    PubMed     Text format     Abstract available


  131. GIANNINI C, Fiorelli F, Colombo A, De Carlo M, et al
    Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy.
    Int J Cardiol. 2016;223:574-580.
    PubMed     Text format     Abstract available


  132. PRENNER SB, Oskouie S, Shah SJ, Sauer AJ, et al
    Repolarization heterogeneity, diastolic dysfunction, and cardiovascular outcomes in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;223:116-117.
    PubMed     Text format    


  133. DE BENEDITTIS G, Rosa GD, D'Ettorre E, Piscitelli P, et al
    Effect of Ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: A chance for slowing progression of heart failure?
    Int J Cardiol. 2016;223:286-288.
    PubMed     Text format    


  134. OMAR HR, Guglin M
    Characteristics and outcomes of patients with acute systolic heart failure discharged within 48hours: A qualification for "observation status" hospital admission.
    Int J Cardiol. 2016;223:129-132.
    PubMed     Text format    


  135. LINDGREN MP, Smith JG, Li X, Sundquist J, et al
    Sibling risk of hospitalization for heart failure - A nationwide study.
    Int J Cardiol. 2016;223:379-384.
    PubMed     Text format     Abstract available


  136. XING F, Hu X, Jiang J, Ma Y, et al
    A meta-analysis of low-dose dopamine in heart failure.
    Int J Cardiol. 2016;222:1003-1011.
    PubMed     Text format     Abstract available


  137. ZHONG Y, Wang N
    Different etiological factors of heart failure may have diverse levels of biomarkers.
    Int J Cardiol. 2016;223:82.
    PubMed     Text format    


  138. LAL S, Turner L, Powell C, Wilson M, et al
    Improvements in left ventricular ejection fraction and quality of life in patients with heart failure who undergo coronary artery bypass surgery.
    Int J Cardiol. 2016;222:671-673.
    PubMed     Text format    


  139. RUIZ G, Andrey JL, Puerto JL, Escobar MA, et al
    Prognosis of heart failure with preserved ejection fraction treated with beta-blockers: A propensity matched study in the community.
    Int J Cardiol. 2016;222:594-602.
    PubMed     Text format     Abstract available


  140. ROCHA BM, Menezes Falcao L
    Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death.
    Int J Cardiol. 2016;223:1035-1044.
    PubMed     Text format     Abstract available


  141. BOJARCZUK J, Josiak K, Kasztura M, Kustrzycka-Kratochwil D, et al
    Iron deficiency in heart failure: Impact on response to cardiac resynchronization therapy.
    Int J Cardiol. 2016;222:133-134.
    PubMed     Text format    


  142. LIN YH, Kuo CC, Lee CM, Chou CH, et al
    5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility.
    Int J Cardiol. 2016;222:895-900.
    PubMed     Text format     Abstract available


  143. DAMLUJI AA, Macon C, Fox A, Garcia G, et al
    The association between in-hospital hemoglobin changes, cardiovascular events, and mortality in acute decompensated heart failure: Results from the ESCAPE trial.
    Int J Cardiol. 2016;222:531-537.
    PubMed     Text format     Abstract available


  144. REYES EB, Ha JW, Firdaus I, Ghazi AM, et al
    Heart failure across Asia: Same healthcare burden but differences in organization of care.
    Int J Cardiol. 2016;223:163-167.
    PubMed     Text format     Abstract available


    July 2016
  145. HONDA S, Nagai T, Sugano Y, Okada A, et al
    Prevalence, determinants, and prognostic significance of delirium in patients with acute heart failure.
    Int J Cardiol. 2016;222:521-527.
    PubMed     Text format     Abstract available


  146. LEE H, Kim TH, Leem J
    Acupuncture for heart failure: A systematic review of clinical studies.
    Int J Cardiol. 2016;222:321-331.
    PubMed     Text format     Abstract available


  147. LU ML, Davila CD, Shah M, Wheeler DS, et al
    Marital status and living condition as predictors of mortality and readmissions among African Americans with heart failure.
    Int J Cardiol. 2016;222:313-318.
    PubMed     Text format     Abstract available


  148. KAJIMOTO K, Minami Y, Sato N, Takano T, et al
    Serum sodium concentration, blood urea nitrogen, and outcomes in patients hospitalized for acute decompensated heart failure.
    Int J Cardiol. 2016;222:195-201.
    PubMed     Text format     Abstract available


  149. CHEN MC, Chang TH, Chang JP, Huang HD, et al
    Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation.
    Int J Cardiol. 2016;222:148-154.
    PubMed     Text format     Abstract available


  150. FARMAKIS D, Alvarez J, Gal TB, Brito D, et al
    Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.
    Int J Cardiol. 2016;222:303-312.
    PubMed     Text format     Abstract available


  151. MARTIN-SANCHEZ FJ, Christ M, Miro O, Peacock WF, et al
    Practical approach on frail older patients attended for acute heart failure.
    Int J Cardiol. 2016;222:62-71.
    PubMed     Text format     Abstract available


  152. BEKFANI T, Pellicori P, Morris DA, Ebner N, et al
    Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.
    Int J Cardiol. 2016;222:41-46.
    PubMed     Text format     Abstract available


  153. BIELECKA-DABROWA A, Sakowicz A, Misztal M, von Haehling S, et al
    Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
    Int J Cardiol. 2016;221:1073-1080.
    PubMed     Text format     Abstract available


  154. CORNELIS J, Beckers P, Taeymans J, Vrints C, et al
    Comparing exercise training modalities in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:867-876.
    PubMed     Text format     Abstract available


  155. OMAR HR, Guglin M
    Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.
    Int J Cardiol. 2016;221:1116-1122.
    PubMed     Text format     Abstract available


  156. MADELAIRE C, Schou M, Nelveg-Kristensen KE, Schmiegelow M, et al
    Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.
    Int J Cardiol. 2016;221:944-950.
    PubMed     Text format     Abstract available


  157. WANG M, Ding H, Kang J, Hu K, et al
    Association between polymorphisms of the HSPB7 gene and Cheyne-Stokes respiration with central sleep apnea in patients with dilated cardiomyopathy and congestive heart failure.
    Int J Cardiol. 2016;221:926-931.
    PubMed     Text format     Abstract available


  158. LAOUTARIS ID, Adamopoulos S, Manginas A, Panagiotakos DB, et al
    Inspiratory work capacity is more severely depressed than inspiratory muscle strength in patients with heart failure: Novel applications for inspiratory muscle training.
    Int J Cardiol. 2016;221:622-626.
    PubMed     Text format     Abstract available


  159. EGUCHI A, Iwasaku T, Okuhara Y, Naito Y, et al
    Long-term administration of tolvaptan increases myocardial remodeling and mortality via exacerbation of congestion in mice heart failure model after myocardial infarction.
    Int J Cardiol. 2016;221:302-309.
    PubMed     Text format     Abstract available


  160. HUYNH QL, Negishi K, Blizzard L, Saito M, et al
    Mild cognitive impairment predicts death and readmission within 30days of discharge for heart failure.
    Int J Cardiol. 2016;221:212-217.
    PubMed     Text format     Abstract available


  161. AUFFRET V, Leurent G, Gilard M, Hacot JP, et al
    Incidence, timing, predictors and impact of acute heart failure complicating ST-segment elevation myocardial infarction in patients treated by primary percutaneous coronary intervention.
    Int J Cardiol. 2016;221:433-442.
    PubMed     Text format     Abstract available


  162. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Piccolo R, Galasso G, et al
    Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Int J Cardiol. 2016;221:359-363.
    PubMed     Text format     Abstract available


  163. BHATT KN, Kalogeropoulos AP, Dunbar SB, Butler J, et al
    Depression in heart failure: Can PHQ-9 help?
    Int J Cardiol. 2016;221:246-250.
    PubMed     Text format     Abstract available


  164. AREVALO-LORIDO JC, Gomez JC, Formiga F, Conde-Martel A, et al
    High serum osmolarity at admission determines a worse outcome in patients with heart failure: Is a new target emerging?
    Int J Cardiol. 2016;221:238-242.
    PubMed     Text format     Abstract available


  165. MATSUE Y, Suzuki M, Torii S, Yamaguchi S, et al
    Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction.
    Int J Cardiol. 2016;221:188-193.
    PubMed     Text format     Abstract available


  166. BANERJEE P, Motiwala A, Mustafa HM, Gani MA, et al
    Does left ventricular diastolic dysfunction progress through stages? Insights from a community heart failure study.
    Int J Cardiol. 2016;221:850-854.
    PubMed     Text format     Abstract available


  167. TROMP J, Meyer S, Mentz RJ, O'Connor CM, et al
    Acute heart failure in the young: Clinical characteristics and biomarker profiles.
    Int J Cardiol. 2016;221:1067-1072.
    PubMed     Text format     Abstract available


  168. JEWISS D, Ostman C, Smart NA
    The effect of resistance training on clinical outcomes in heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:674-681.
    PubMed     Text format     Abstract available


  169. BANFI C, Agostoni P
    Surfactant protein B: From biochemistry to its potential role as diagnostic and prognostic marker in heart failure.
    Int J Cardiol. 2016;221:456-462.
    PubMed     Text format     Abstract available


  170. PERCIACCANTE A, Coralli A, Bianucci R
    Has Saint Anthony of Padua suffered from congestive heart failure?
    Int J Cardiol. 2016;221:110-111.
    PubMed     Text format    


  171. AMIR O, Azzam ZS, Gaspar T, Faranesh-Abboud S, et al
    Validation of remote dielectric sensing (ReDS) technology for quantification of lung fluid status: Comparison to high resolution chest computed tomography in patients with and without acute heart failure.
    Int J Cardiol. 2016;221:841-846.
    PubMed     Text format     Abstract available


  172. SAIRAKU A, Yoshida Y, Nakano Y, Hirayama H, et al
    Don't expect left ventricular reverse remodeling after cardiac resynchronization therapy in patients with systolic heart failure and atrioventricular block: A multicenter study.
    Int J Cardiol. 2016;221:597-600.
    PubMed     Text format     Abstract available


    June 2016
  173. CEBRIAN-CUENCA AM, Orozco-Beltran D, Navarro-Perez J, Franch-Nadal J, et al
    Saxagliptin and risk of heart failure hospitalization: Concern or miscalculation?
    Int J Cardiol. 2016;220:573-574.
    PubMed     Text format    


  174. CORNELIS J, Vrints C, Vanroy C, Vissers D, et al
    Letter by Cornelis et al. regarding article, "Exercise oscillatory ventilation in heart failure".
    Int J Cardiol. 2016;220:759-760.
    PubMed     Text format    


  175. MAKUBI A, Hage C, Sartipy U, Lwakatare J, et al
    Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF).
    Int J Cardiol. 2016;220:750-758.
    PubMed     Text format     Abstract available


  176. VAZIR A, Simpkin VL, Marino P, Ludman A, et al
    Association of haemodynamic changes measured by serial central venous saturation during ultrafiltration for acutely decompensated heart failure with diuretic resistance and change in renal function.
    Int J Cardiol. 2016;220:618-622.
    PubMed     Text format     Abstract available


  177. EDWARDS MK, Loprinzi PD
    Sedentary behavior & health-related quality of life among congestive heart failure patients.
    Int J Cardiol. 2016;220:520-523.
    PubMed     Text format     Abstract available


  178. PIOTROWICZ E, Piepoli MF, Jaarsma T, Lambrinou E, et al
    Telerehabilitation in heart failure patients: The evidence and the pitfalls.
    Int J Cardiol. 2016;220:408-413.
    PubMed     Text format     Abstract available


  179. PARK SY, Trinity JD, Gifford JR, Diakos NA, et al
    Mitochondrial function in heart failure: The impact of ischemic and non-ischemic etiology.
    Int J Cardiol. 2016;220:711-717.
    PubMed     Text format     Abstract available


  180. NUNEZ J, Nunez E, Minana G, Carratala A, et al
    Serum neprilysin and recurrent hospitalizations after acute heart failure.
    Int J Cardiol. 2016;220:742-744.
    PubMed     Text format    


  181. ZWISLER AD, Norton RJ, Dean SG, Dalal H, et al
    Home-based cardiac rehabilitation for people with heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:963-969.
    PubMed     Text format     Abstract available


  182. FURIHATA T, Kinugawa S, Fukushima A, Takada S, et al
    Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure.
    Int J Cardiol. 2016;220:483-487.
    PubMed     Text format     Abstract available


  183. SINIORAKIS EE, Arapi SM, Panta SG, Pyrgakis VN, et al
    Emergency department triage of acute heart failure triggered by pneumonia; when an intensive care unit is needed?
    Int J Cardiol. 2016;220:479-482.
    PubMed     Text format     Abstract available


  184. MOREIRA-SILVA S, Urbano J, Moura MC, Ferreira-Coimbra J, et al
    Liver cytolysis in acute heart failure: What does it mean? Clinical profile and outcomes of a prospective hospital cohort.
    Int J Cardiol. 2016;221:422-427.
    PubMed     Text format     Abstract available


  185. KATZ A, Maor E, Leor J, Klempfner R, et al
    Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
    Int J Cardiol. 2016;221:198-204.
    PubMed     Text format     Abstract available


  186. OMAR HR, Guglin M
    Longitudinal BNP follow-up as a marker of treatment response in acute heart failure: Relationship with objective markers of decongestion.
    Int J Cardiol. 2016;221:167-170.
    PubMed     Text format     Abstract available


  187. OZAWA K, Funabashi N, Sugiura A, Kobayashi Y, et al
    Layer specific strain measurement and its relationship to heart failure indicators in systemic autoimmune disorder patients: A multi-layer transthoracic echocardiography study.
    Int J Cardiol. 2016;220:693-699.
    PubMed     Text format    


  188. DENG J, Zhong Q
    Advanced research on the microRNA mechanism in heart failure.
    Int J Cardiol. 2016;220:61-64.
    PubMed     Text format     Abstract available


  189. GU J, Fan YQ, Han ZH, Fan L, et al
    Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.
    Int J Cardiol. 2016;220:56-60.
    PubMed     Text format     Abstract available


  190. PAN WQ, He YH, Su Q, Yang J, et al
    Association of decreased serum vasostatin-2 level with ischemic chronic heart failure and with MACE in 3-year follow-up: Vasostatin-2 prevents heart failure in myocardial infarction rats.
    Int J Cardiol. 2016;221:1-11.
    PubMed     Text format     Abstract available


  191. OMAR HR, Guglin M
    Hypothermia is an independent predictor of short and intermediate term mortality in acute systolic heart failure: Insights from the ESCAPE trial.
    Int J Cardiol. 2016;220:729-733.
    PubMed     Text format     Abstract available


  192. CHANG CH, Chang YC, Lin JW, Caffrey JL, et al
    No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan.
    Int J Cardiol. 2016;220:14-20.
    PubMed     Text format     Abstract available


  193. BERTON G, Cordiano R, Cavuto F, Bagato F, et al
    Heart failure in women and men during acute coronary syndrome and long-term cardiovascular mortality (the ABC-3* Study on Heart Disease) (*Adria, Bassano, Conegliano, and Padova Hospitals).
    Int J Cardiol. 2016;220:538-543.
    PubMed     Text format     Abstract available


  194. SOKORELI I, de Vries JJ, Riistama JM, Pauws SC, et al
    Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure.
    Int J Cardiol. 2016;220:202-207.
    PubMed     Text format     Abstract available


  195. FARMAKIS D, Filippatos G, Parissis J, Karavidas A, et al
    Structured discharge instructions for hospitalized heart failure patients to improve guideline implementation and patient outcomes.
    Int J Cardiol. 2016;220:143-145.
    PubMed     Text format    


  196. RUIGOMEZ A, Michel A, Martin-Perez M, Garcia Rodriguez LA, et al
    Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality.
    Int J Cardiol. 2016;220:855-861.
    PubMed     Text format     Abstract available


  197. SALAMANCA-BAUTISTA P, Conde-Martel A, Aramburu-Bodas O, Formiga F, et al
    Precipitating factors of heart failure admission: Differences related to age and left ventricular ejection fraction.
    Int J Cardiol. 2016;219:150-155.
    PubMed     Text format     Abstract available


  198. ORSZULAK M, Mizia-Stec K, Siennicka A, Goscinska-Bis K, et al
    Differences of psychological features in patients with heart failure with regard to gender and aetiology - Results of a CAPS-LOCK-HF (Complex Assessment of Psychological Status Located in Heart Failure) study.
    Int J Cardiol. 2016;219:380-386.
    PubMed     Text format     Abstract available


  199. MARCINKIEWICZ-SIEMION M, Ciborowski M, Kretowski A, Musial WJ, et al
    Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
    Int J Cardiol. 2016;219:156-163.
    PubMed     Text format     Abstract available


  200. ZUPAN MEZNAR A, Berden P, Lainscak M
    Left ventricular metastasis of soft tissue sarcoma causing heart failure: Presentation of two cases.
    Int J Cardiol. 2016;219:119-120.
    PubMed     Text format    


  201. WANG S, Liu M, Fang F, Shang Q, et al
    Prognostic value of acoustic cardiography in patients with chronic heart failure.
    Int J Cardiol. 2016;219:121-126.
    PubMed     Text format     Abstract available


    May 2016
  202. D'ONOFRIO A, Iuliano A, De Simone A, Pecora D, et al
    Electrical remodeling after cardiac resynchronization therapy and its relationship with the anatomical remodeling.
    Int J Cardiol. 2016;211:86-7.
    PubMed     Text format    


  203. NIEMINEN MS, Buerke M, Cohen-Solal A, Costa S, et al
    The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.
    Int J Cardiol. 2016;218:150-157.
    PubMed     Text format     Abstract available


  204. BAUM C, Ojeda FM, Wild PS, Rzayeva N, et al
    Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population.
    Int J Cardiol. 2016;218:298-304.
    PubMed     Text format     Abstract available


  205. KUBE J, Ebner N, Jankowska EA, Rozentryt P, et al
    The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
    Int J Cardiol. 2016;219:84-91.
    PubMed     Text format     Abstract available


  206. GEORGIOPOULOU VV, Tang WH, Giamouzis G, Li S, et al
    Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium.
    Int J Cardiol. 2016;218:136-143.
    PubMed     Text format     Abstract available


  207. OMAR HR, Guglin M
    Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes.
    Int J Cardiol. 2016;218:120-125.
    PubMed     Text format     Abstract available


  208. COGLIATI C, Casazza G, Ceriani E, Torzillo D, et al
    Lung ultrasound and short-term prognosis in heart failure patients.
    Int J Cardiol. 2016;218:104-108.
    PubMed     Text format     Abstract available


  209. AL-KINDI SG, ElAmm C, Ginwalla M, Mehanna E, et al
    Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.
    Int J Cardiol. 2016;218:43-46.
    PubMed     Text format     Abstract available


  210. DE ANGELIS A, Cappetta D, Piegari E, Rinaldi B, et al
    Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;217:69-79.
    PubMed     Text format     Abstract available


  211. KANG J, Park J, Lee JM, Park JJ, et al
    The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: A meta-analysis of randomized clinical trials.
    Int J Cardiol. 2016;218:12-22.
    PubMed     Text format     Abstract available


  212. VOLTERRANI M, Iellamo F, Senni M, Piepoli MF, et al
    Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition.
    Int J Cardiol. 2016 May 7. pii: S0167-5273(16)30876.
    PubMed     Text format     Abstract available


  213. VAN RIET EE, Hoes AW, Limburg A, Landman MA, et al
    Effect of training general practitioners in drug treatment of newly detected heart failure patients with reduced or preserved ejection fraction: A cluster randomized trial.
    Int J Cardiol. 2016;217:174-182.
    PubMed     Text format     Abstract available


  214. RIM TH, Oh J, Kang SM, Kim SS, et al
    Association between retinal vein occlusion and risk of heart failure: A 12-year nationwide cohort study.
    Int J Cardiol. 2016;217:122-127.
    PubMed     Text format     Abstract available


    April 2016
  215. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
    ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
    Int J Cardiol. 2016;217:128-134.
    PubMed     Text format     Abstract available


  216. BOSSEAU C, Donal E
    Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients.
    Int J Cardiol. 2016 Apr 22. pii: S0167-5273(16)30278.
    PubMed     Text format    


  217. KOULAOUZIDIS G, Iakovidis DK, Clark AL
    Telemonitoring predicts in advance heart failure admissions.
    Int J Cardiol. 2016;216:78-84.
    PubMed     Text format     Abstract available


  218. HIDALGO FJ, Anguita M, Castillo JC, Rodriguez S, et al
    Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
    Int J Cardiol. 2016;217:7-11.
    PubMed     Text format     Abstract available


  219. ONOUE Y, Izumiya Y, Hanatani S, Tanaka T, et al
    A simple sarcopenia screening test predicts future adverse events in patients with heart failure.
    Int J Cardiol. 2016;215:301-306.
    PubMed     Text format     Abstract available


  220. KINOSHITA K, Kawai M, Minai K, Ogawa K, et al
    Potent influence of obesity on suppression of plasma B-type natriuretic peptide levels in patients with acute heart failure: An approach using covariance structure analysis.
    Int J Cardiol. 2016;215:283-290.
    PubMed     Text format     Abstract available


  221. CARROLL R, Mudge A, Suna J, Denaro C, et al
    Prescribing and up-titration in recently hospitalized heart failure patients attending a disease management program.
    Int J Cardiol. 2016;216:121-127.
    PubMed     Text format     Abstract available


  222. DAMATTO RL, Lima AR, Martinez PF, Cezar MD, et al
    Myocardial myostatin in spontaneously hypertensive rats with heart failure.
    Int J Cardiol. 2016;215:384-387.
    PubMed     Text format     Abstract available


  223. KLOPPE A, Lawo T, Mijic D, Schiedat F, et al
    Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration.
    Int J Cardiol. 2016;209:291-5.
    PubMed     Text format     Abstract available


  224. CANDEL FJ, Matesanz M, Martin-Sanchez FJ, Gonzalez Del Castillo JM, et al
    Monitoring of high-dose fosfomycin guided by NT-proBNP.
    Int J Cardiol. 2016;209:131-2.
    PubMed     Text format    


  225. POURAFKARI L, Wang CK, Schwartz M, Nader ND, et al
    Does shock index provide prognostic information in acute heart failure?
    Int J Cardiol. 2016;215:140-142.
    PubMed     Text format    


  226. SHIRAISHI M, Murakami T, Nawa T, Kobayashi H, et al
    Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant.
    Int J Cardiol. 2016;215:127-128.
    PubMed     Text format    


  227. KIVIKKO M, Pollesello P, Tarvasmaki T, Sarapohja T, et al
    Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.
    Int J Cardiol. 2016;215:26-31.
    PubMed     Text format     Abstract available


  228. BRISCO MA, Zile MR, Ter Maaten JM, Hanberg JS, et al
    The risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.
    Int J Cardiol. 2016;215:521-526.
    PubMed     Text format     Abstract available


  229. VIEIRA JL, Guimaraes GV, de Andre PA, Saldiva PH, et al
    Effects of reducing exposure to air pollution on submaximal cardiopulmonary test in patients with heart failure: Analysis of the randomized, double-blind and controlled FILTER-HF trial.
    Int J Cardiol. 2016;215:92-97.
    PubMed     Text format     Abstract available


  230. GASTELURRUTIA P, Cuba-Gyllensten I, Lupon J, Zamora E, et al
    Wearable vest for pulmonary congestion tracking and prognosis in heart failure: A pilot study.
    Int J Cardiol. 2016;215:77-79.
    PubMed     Text format    


  231. SLAWUTA A, Mazur G, Malecka B, Gajek J, et al
    Permanent His bundle pacing - An optimal treatment method in heart failure patients with AF and narrow QRS.
    Int J Cardiol. 2016;214:451-452.
    PubMed     Text format    


  232. FENG YX, Yang LJ, Li T, Dong HW, et al
    Association between elevated D-dimer levels and adverse outcome in patients with acute heart failure.
    Int J Cardiol. 2016;214:415-416.
    PubMed     Text format    


  233. WANG J, Hu X, Jiang H
    MSCs modified with HO-1 gene transplantation: A novel therapeutic approach for attenuating heart failure.
    Int J Cardiol. 2016;214:159-160.
    PubMed     Text format    


  234. FUKUTA H, Goto T, Wakami K, Ohte N, et al
    The effect of statins on mortality in heart failure with preserved ejection fraction: a meta-analysis of propensity score analyses.
    Int J Cardiol. 2016;214:301-306.
    PubMed     Text format     Abstract available


  235. SMITH S, Rossignol P, Willis S, Zannad F, et al
    Neural modulation for hypertension and heart failure.
    Int J Cardiol. 2016;214:320-330.
    PubMed     Text format     Abstract available


  236. LOMBARDI C, Fanfulla F, Parati G
    Treatment of central sleep apnea in heart failure patients: Benefit or harm?
    Int J Cardiol. 2016;214:254-255.
    PubMed     Text format    


  237. ZIAEI F, Zaman M, Rasoul D, Gorantla RS, et al
    The prevalence of atrial fibrillation amongst heart failure patients increases with age.
    Int J Cardiol. 2016;214:410-411.
    PubMed     Text format    


    March 2016
  238. WANG J, Hu X, Jiang H
    HDAC inhibition: A novel therapeutic approach for attenuating heart failure by suppressing cardiac remodeling.
    Int J Cardiol. 2016;214:41-42.
    PubMed     Text format    


  239. LOPRINZI PD
    Physical activity, weight status, and mortality among congestive heart failure patients.
    Int J Cardiol. 2016;214:92-94.
    PubMed     Text format     Abstract available


  240. MINANA G, Rumiz E, Palau P, Valero E, et al
    Plasma neutrophil gelatinase-associated lipocalin and long-term mortality in patients with acute heart failure and normal renal function.
    Int J Cardiol. 2016;214:51-53.
    PubMed     Text format    


  241. KOTECHA D
    Letter: Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients - Response.
    Int J Cardiol. 2016 Mar 25. pii: S0167-5273(16)30529.
    PubMed     Text format    


  242. OH PC, Koh KK
    Recurrent stress-induced cardiomyopathy presented with acute decompensated heart failure.
    Int J Cardiol. 2016;212:307-309.
    PubMed     Text format    


  243. GUO WQ, Li L
    Angiotensin converting enzyme inhibitors for heart failure with reduced ejection fraction or left ventricular dysfunction: A complementary network meta-analyses.
    Int J Cardiol. 2016;214:10-12.
    PubMed     Text format    


  244. ROSSI F, Mascolo A, Mollace V
    The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure.
    Int J Cardiol. 2016 Mar 23. pii: S0167-5273(16)30502.
    PubMed     Text format     Abstract available


  245. RADULOVIC B, Potocnjak I, Dokoza Teresak S, Trbusic M, et al
    Hypochloraemia as a predictor of developing hyponatraemia and poor outcome in acute heart failure patients.
    Int J Cardiol. 2016;212:237-241.
    PubMed     Text format     Abstract available


  246. BACURAU AV, Jannig PR, de Moraes WM, Cunha TF, et al
    Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice.
    Int J Cardiol. 2016;214:137-147.
    PubMed     Text format     Abstract available


  247. OHUCHI H, Hayama Y, Negishi J, Noritake K, et al
    Heart failure with preserved right ventricular ejection fraction in postoperative adults with congenital heart disease: A subtype of severe right ventricular pathophysiology.
    Int J Cardiol. 2016;212:223-231.
    PubMed     Text format     Abstract available


  248. KUNDU A, Sardar P, Ghosh S, Patel P, et al
    Risk of heart failure with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;212:203-205.
    PubMed     Text format    


  249. KAJIMOTO K, Sato N, Takano T
    Association between age, time after hospitalization, and survival among patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2016;212:151-153.
    PubMed     Text format    


  250. LOPRINZI PD
    Physical activity with alanine aminotransferase and gamma-glutamyltransferase among congestive heart failure patients.
    Int J Cardiol. 2016;212:61-62.
    PubMed     Text format    


  251. DURMAZ O, Olgun Kucuk H, Kucuk U
    Intricate associations between heart failure, depression and vitamin D.
    Int J Cardiol. 2016;212:121.
    PubMed     Text format    


  252. SU JL, Zhang SG, Gao RJ, Han QF, et al
    Red cell distribution width is a predictor of mortality in patients with chronic heart failure.
    Int J Cardiol. 2016;212:79-81.
    PubMed     Text format    


  253. YI X, Li X, Jiang X
    Carabin: Endogenous calcineurin inhibitor, a potential diagnostic and therapeutic target for cardiac hypertrophy in heart failure.
    Int J Cardiol. 2016;212:57-58.
    PubMed     Text format    


  254. ELEUTERI E, Di Stefano A, Giordano A, Corra U, et al
    Prognostic value of angiopoietin-2 in patients with chronic heart failure.
    Int J Cardiol. 2016;212:364-368.
    PubMed     Text format     Abstract available


  255. YOSHIHISA A, Suzuki S, Kanno Y, Takiguchi M, et al
    Prognostic significance of periodic leg movements during sleep in heart failure patients.
    Int J Cardiol. 2016;212:11-13.
    PubMed     Text format    


  256. LOPRINZI PD
    Implications of light-intensity physical activity in improving health-related quality of life among congestive heart failure patients.
    Int J Cardiol. 2016;212:16-17.
    PubMed     Text format    


  257. STEWART S, Riegel B, Boyd C, Ahamed Y, et al
    Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.
    Int J Cardiol. 2016;212:1-10.
    PubMed     Text format     Abstract available


  258. JONSSON A, Hallberg AC, Edner M, Lund LH, et al
    A comprehensive assessment of the association between anemia, clinical covariates and outcomes in a population-wide heart failure registry.
    Int J Cardiol. 2016;211:124-131.
    PubMed     Text format    


  259. GANGA HV, Jantz J, Puppala VK
    The impact of iron deficiency on exercise capacity in chronic heart failure patients.
    Int J Cardiol. 2016 Mar 2. pii: S0167-5273(16)30122.
    PubMed     Text format    


  260. PARENICA J, Kala P, Pavkova MG, Tomandl J, et al
    Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study
    Int J Cardiol. 2016;211:96-104.
    PubMed     Text format     Abstract available


  261. KONGWATCHARAPONG J, Dilokthornsakul P, Nathisuwan S, Phrommintikul A, et al
    Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials.
    Int J Cardiol. 2016;211:88-95.
    PubMed     Text format     Abstract available


  262. BOONMAN-DE WINTER LJ, van Stel HF, Hoes AW, Landman MJ, et al
    Health status of older patients with type 2 diabetes and screen-detected heart failure is significantly lower than those without.
    Int J Cardiol. 2016;211:79-83.
    PubMed     Text format    


  263. LEE JF, Barrett-O'Keefe Z, Nelson AD, Garten RS, et al
    Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;211:14-21.
    PubMed     Text format     Abstract available


  264. LAINSCAK M, Coats AJ
    The PARADIGM of ARNI's: Assessing reasons for non-implementation in heart failure.
    Int J Cardiol. 2016;212:187-189.
    PubMed     Text format     Abstract available


  265. JOSEPH S, Costanzo MR
    A novel therapeutic approach for central sleep apnea: Phrenic nerve stimulation by the remede(R) System.
    Int J Cardiol. 2016;206 Suppl:S28-34.
    PubMed     Text format     Abstract available


  266. FLINTA I, Ponikowski P
    Relationship between central sleep apnea and Cheyne-Stokes Respiration.
    Int J Cardiol. 2016;206 Suppl:S8-12.
    PubMed     Text format     Abstract available


  267. KHAYAT RN, Abraham WT
    Current treatment approaches and trials in central sleep apnea.
    Int J Cardiol. 2016;206 Suppl:S22-7.
    PubMed     Text format     Abstract available


    February 2016
  268. NAUGHTON MT
    Epidemiology of central sleep apnoea in heart failure.
    Int J Cardiol. 2016 Feb 26. pii: S0167-5273(16)30359.
    PubMed     Text format     Abstract available


  269. COATS AJ, Shewan LG
    Measuring therapeutic efficacy in the treatment of CSA in patients with heart failure.
    Int J Cardiol. 2016 Feb 24. pii: S0167-5273(16)30356.
    PubMed     Text format     Abstract available


  270. COATS AJ, Abraham WT
    Central sleep apnoea in heart failure - An important issue for the modern heart failure cardiologist.
    Int J Cardiol. 2016 Feb 24. pii: S0167-5273(16)30353.
    PubMed     Text format    


  271. CORRA U
    Exercise oscillatory ventilation in heart failure.
    Int J Cardiol. 2016 Feb 23. pii: S0167-5273(16)30355.
    PubMed     Text format     Abstract available


  272. VASSILIOU VS, Patel HC, Rosen SD, Auger D, et al
    Left atrial dilation in patients with heart failure and preserved ejection fraction: Insights from cardiovascular magnetic resonance.
    Int J Cardiol. 2016;210:158-160.
    PubMed     Text format    


  273. KOUNIS NG, Soufras GD, Lianas D, Patsouras N, et al
    Heparin-induced thrombocytopenia, allergy to heparins, heart failure, thrombi, and the Kounis syndrome.
    Int J Cardiol. 2016 Feb 20. pii: S0167-5273(16)30340.
    PubMed     Text format    


  274. TANAKA A, Nakamura T, Sato E, Node K, et al
    Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome.
    Int J Cardiol. 2016;210:1-3.
    PubMed     Text format    


  275. CHATTERJEE NA, Singh JP, Szymonifka J, Deano RC, et al
    Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.
    Int J Cardiol. 2016;205:43-9.
    PubMed     Text format     Abstract available


  276. ABDUL-RAHIM AH, MacIsaac RL, Jhund PS, Petrie MC, et al
    Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial.
    Int J Cardiol. 2016;209:310-316.
    PubMed     Text format     Abstract available


  277. KONDO M, Kohno T, Kohsaka S, Fukuoka R, et al
    Enhanced oxidative stress is associated with sleep-disordered breathing and obesity in patients with heart failure.
    Int J Cardiol. 2016;209:133-135.
    PubMed     Text format    


  278. MARRA AM, Arcopinto M, Salzano A, Bobbio E, et al
    Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure.
    Int J Cardiol. 2016;209:114-117.
    PubMed     Text format    


  279. KAWADA T
    Antidepressant use, clinical depression and mortality in patients with heart failure.
    Int J Cardiol. 2016;209:68-69.
    PubMed     Text format    


  280. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
    Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
    Int J Cardiol. 2016;209:1-6.
    PubMed     Text format     Abstract available


  281. ARMENI P, Boscolo PR, Tarricone R, Capodanno D, et al
    Real-world cost effectiveness of MitraClip combined with Medical Therapy Versus Medical therapy alone in patients with moderate or severe mitral regurgitation.
    Int J Cardiol. 2016;209:153-160.
    PubMed     Text format     Abstract available


  282. MENET A, Guyomar Y, Ennezat PV, Graux P, et al
    Prognostic value of left ventricular reverse remodeling and performance improvement after cardiac resynchronization therapy: A prospective study.
    Int J Cardiol. 2016;204:6-11.
    PubMed     Text format     Abstract available


    January 2016
  283. VROMEN T, Kraal JJ, Kuiper J, Spee RF, et al
    The influence of training characteristics on the effect of aerobic exercise training in patients with chronic heart failure: A meta-regression analysis.
    Int J Cardiol. 2016;208:120-127.
    PubMed     Text format     Abstract available


  284. KAWADA T
    Survival risk of salivary cortisol and serum N-terminal pro-hormone B-type natriuretic peptide in patients with systolic heart failure.
    Int J Cardiol. 2016 Jan 25. pii: S0167-5273(16)30193.
    PubMed     Text format    


  285. BEHNES M, Bertsch T, Weiss C, Ahmad-Nejad P, et al
    Response to letter: Device therapy and aldosterone antagonists in the prognosis of heart failure.
    Int J Cardiol. 2016 Jan 21. pii: S0167-5273(16)30198.
    PubMed     Text format    


  286. POLLESELLO P, Papp Z, Papp JG
    Calcium sensitizers: What have we learned over the last 25 years?
    Int J Cardiol. 2016;203:543-8.
    PubMed     Text format     Abstract available


  287. HUANG Y, Mai L, Cai X, Hu Y, et al
    Stem cell therapy for heart disease-Meta-analysis may be misleading.
    Int J Cardiol. 2016;203:351-2.
    PubMed     Text format    


  288. KITADA S, Schulze PC, Jin Z, Clerkin KJ, et al
    Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Int J Cardiol. 2016;203:929-35.
    PubMed     Text format     Abstract available


  289. SINNING C, Kozlik-Feldmann R, Demir C, Blankenberg S, et al
    Long-term course of a patient with congenital corrected transposition of the great arteries and dextrocardia--The Fisher King.
    Int J Cardiol. 2016;203:436-7.
    PubMed     Text format    


  290. TSCHOPE C, Van Linthout S, Spillmann F, Klein O, et al
    Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF.
    Int J Cardiol. 2016;203:1061-6.
    PubMed     Text format    


  291. FUNG E, Fong MW, Correa AJ, Yoon AJ, et al
    Fulminant eosinophilic myocarditis following ICD implantation in a patient with undisclosed nickel allergy.
    Int J Cardiol. 2016;203:1018-9.
    PubMed     Text format    


  292. MADIAS JE
    Takotsubo syndrome/QTc interval prolongation/myocardial edema/cardiac sympathetic denervation/cardiac arrhythmias: A quintet needing exploration.
    Int J Cardiol. 2016;203:259-61.
    PubMed     Text format    


  293. NUNEZ J, Dominguez E, Ramon JM, Nunez E, et al
    Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction.
    Int J Cardiol. 2016;207:365-367.
    PubMed     Text format    


  294. PIPER SE, de Courcey J, Sherwood RA, Amin-Youssef GF, et al
    Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: A pilot study.
    Int J Cardiol. 2016;207:279-281.
    PubMed     Text format    


  295. MUNOZ MA, Real J, Del Val JL, Vinyoles E, et al
    Determinants of survival and hospitalization in older, heart failure patients receiving home healthcare.
    Int J Cardiol. 2016;207:145-149.
    PubMed     Text format     Abstract available


  296. JOHANSSON P, Alehagen U, van der Wal MH, Svensson E, et al
    Vitamin D levels and depressive symptoms in patients with chronic heart failure.
    Int J Cardiol. 2016;207:185-189.
    PubMed     Text format     Abstract available


  297. ONO R, Funabashi N, Takaoka H, Ozawa K, et al
    Massive myocardial aneurysm due to inferior to posterior myocardial infarction complicated with right-sided heart failure in a 36-year-old male.
    Int J Cardiol. 2016;209:98-102.
    PubMed     Text format    


  298. MICHEL A, Martin-Perez M, Ruigomez A, Garcia Rodriguez LA, et al
    Incidence and risk factors for severe renal impairment after first diagnosis of heart failure: A cohort and nested case-control study in UK general practice.
    Int J Cardiol. 2016;207:252-257.
    PubMed     Text format     Abstract available


  299. LOPRINZI PD
    Physical activity and peripheral arterial disease among patients with coronary artery disease or congestive heart failure.
    Int J Cardiol. 2016;207:110-111.
    PubMed     Text format    


  300. CURCIO A, Cascini GL, De Rosa S, Pasceri E, et al
    I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation.
    Int J Cardiol. 2016;207:107-109.
    PubMed     Text format    


  301. ALHAJ EK
    Can unilateral adrenalectomy be an option in modulating autonomic nervous system in heart failure?
    Int J Cardiol. 2016;207:50-52.
    PubMed     Text format     Abstract available


  302. CARTER P, Reynolds J, Carter A, Potluri S, et al
    The impact of psychiatric comorbidities on the length of hospital stay in patients with heart failure.
    Int J Cardiol. 2016;207:292-296.
    PubMed     Text format     Abstract available


  303. DIXON DL, Bersten AD, Lawrence MD, Bihari S, et al
    Lung surfactant in chronic heart failure patients.
    Int J Cardiol. 2016;207:213-214.
    PubMed     Text format    


  304. KAYA H, Beton O, Yilmaz MB
    Atrial fibrillation and D dimer levels for patients with acute decompensated heart failure.
    Int J Cardiol. 2016;207:136.
    PubMed     Text format    


  305. LIU M, Fang F, Luo XX, Shlomo BH, et al
    Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study.
    Int J Cardiol. 2016;206:122-126.
    PubMed     Text format     Abstract available


  306. IMRAN TF, Shah R, Ha AS, Thomas R, et al
    Heart failure associated with small molecule tyrosine kinase inhibitors.
    Int J Cardiol. 2016;206:110-111.
    PubMed     Text format    


  307. LOPRINZI PD
    Objectively-measured physical activity and sleep apnea among congestive heart failure patients.
    Int J Cardiol. 2016;206:82-83.
    PubMed     Text format    


  308. BAVISHI C, Khan AR, Ather S
    Reply to the letter "Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality".
    Int J Cardiol. 2016;206:56-57.
    PubMed     Text format    


  309. FAN Z, Yang J, Yang J, Yang C, et al
    HDAC inhibition: A novel therapeutic approach for atherosclerosis.
    Int J Cardiol. 2016;202:722-3.
    PubMed     Text format    


  310. DONAZZAN L, Rigolli M, De Simone V, Bergamini C, et al
    Cardiac resynchronization therapy: Twelve-month effects of echocardiographic atrio-ventricular and inter-ventricular delay optimization. Rationale and design of the CARTEDO trial.
    Int J Cardiol. 2016;202:185-7.
    PubMed     Text format    


  311. HUANG JH, Lin YK, Hsieh MH, Chiu WC, et al
    Age and thyroid hormone replacement delays the recovery from amiodarone-induced hypothyroidism.
    Int J Cardiol. 2016;202:561-3.
    PubMed     Text format    


  312. LAINSCAK M, von Haehling S, Anker SD
    PURE muscle and more.
    Int J Cardiol. 2016;202:446-7.
    PubMed     Text format    


  313. SANTAS E, Nunez J
    Prognostic implications of pericardial effusion: The importance of underlying etiology.
    Int J Cardiol. 2016;202:407.
    PubMed     Text format    


  314. SOMMESE L, Valverde CA, Blanco P, Castro MC, et al
    Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate.
    Int J Cardiol. 2016;202:394-406.
    PubMed     Text format     Abstract available


    December 2015
  315. XIE W, Zheng F, Song X, Zhong B, et al
    Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Int J Cardiol. 2015;205:65-71.
    PubMed     Text format     Abstract available


  316. HIGASHI K, Murakami T, Ishikawa Y, Itoi T, et al
    Efficacy and safety of tolvaptan for pediatric patients with congestive heart failure. Multicenter survey in the working group of the Japanese Society of PEdiatric Circulation and Hemodynamics (J-SPECH).
    Int J Cardiol. 2015;205:37-42.
    PubMed     Text format     Abstract available


  317. DOKAINISH H, Teo K, Zhu J, Roy A, et al
    Heart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study.
    Int J Cardiol. 2015;204:133-141.
    PubMed     Text format     Abstract available


  318. EBNER N, Jankowska EA, Ponikowski P, Lainscak M, et al
    The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
    Int J Cardiol. 2015;205:6-12.
    PubMed     Text format     Abstract available


  319. CAPUANO A, Scavone C, Vitale C, Sportiello L, et al
    Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
    Int J Cardiol. 2015;200:15-9.
    PubMed     Text format     Abstract available


    November 2015
  320. DEMISSEI BG, Cleland JG, O'Connor CM, Metra M, et al
    Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients.
    Int J Cardiol. 2015;204:164-171.
    PubMed     Text format     Abstract available


  321. BANERJEE P
    Heart failure with preserved ejection fraction: A clinical crisis.
    Int J Cardiol. 2015;204:198-199.
    PubMed     Text format     Abstract available


  322. YOKOKAWA T, Sugano Y, Shimouchi A, Shibata A, et al
    A case of acute decompensated heart failure evaluated by series of exhaled acetone concentrations as noninvasive biomarker of heart failure severity.
    Int J Cardiol. 2015;204:112-113.
    PubMed     Text format    


  323. LUPON J, Sanders-van Wijk S, Januzzi JL, de Antonio M, et al
    Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study.
    Int J Cardiol. 2015;204:242-247.
    PubMed     Text format     Abstract available


  324. LEVICK SP, Melendez GC
    Targeting substance P and relaxin: A future combination therapy approach for heart failure?
    Int J Cardiol. 2015;204:154-155.
    PubMed     Text format    


  325. CONSUEGRA-SANCHEZ L, Jaulent-Huertas L, Vicente-Gilabert M, Escudero-Garcia G, et al
    Heart failure complicating acute myocardial infarction. Does the time of presentation matter?
    Int J Cardiol. 2015;204:48-50.
    PubMed     Text format    


  326. MINAMI Y, Haruki S, Jujo K, Itani R, et al
    Elevated D-dimer levels predict an adverse outcome in hospitalized patients with acute decompensated heart failure.
    Int J Cardiol. 2015;204:42-44.
    PubMed     Text format    


  327. GELLEN B, Canoui-Poitrine F, Boyer L, Drouot X, et al
    Apnea-hypopnea and desaturations in heart failure with reduced ejection fraction: Are we aiming at the right target?
    Int J Cardiol. 2015;203:1022-1028.
    PubMed     Text format     Abstract available


  328. LOPRINZI PD
    The association of serum cotinine and congestive heart failure diagnosis among never smokers: Considerations by physical activity behavior.
    Int J Cardiol. 2015;203:1042-1043.
    PubMed     Text format    


  329. TARGHER G, Dauriz M, Tavazzi L, Temporelli PL, et al
    Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
    Int J Cardiol. 2015;203:587-593.
    PubMed     Text format    


  330. LOPRINZI PD
    The effects of free-living physical activity on mortality after congestive heart failure diagnosis.
    Int J Cardiol. 2015;203:598-599.
    PubMed     Text format    


  331. BRUNO N, Ter Maaten JM, Ovchinnikova ES, Vegter EL, et al
    MicroRNAs relate to early worsening of renal function in patients with acute heart failure.
    Int J Cardiol. 2015;203:564-569.
    PubMed     Text format     Abstract available


  332. PALAU P, Dominguez E, Nunez E, Sanchis J, et al
    Six-minute walk test in moderate to severe heart failure with preserved ejection fraction: Useful for functional capacity assessment?
    Int J Cardiol. 2015;203:800-802.
    PubMed     Text format    


  333. BOSCHETTO P, Vaccari A, Groccia R, Casimirri E, et al
    Forced expiratory volume in one second: Predicting return to work within 3months after chronic heart failure diagnosis.
    Int J Cardiol. 2015;203:798-799.
    PubMed     Text format    


  334. MUELLER KA, Schwille J, Vollmer S, Ehinger E, et al
    Prognostic impact of macrophage migration inhibitory factor in patients with non-ischemic heart failure undergoing endomyocardial biopsy.
    Int J Cardiol. 2015;203:656-659.
    PubMed     Text format    


  335. CORRA U, Agostoni P, Giordano A, Cattadori G, et al
    The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.
    Int J Cardiol. 2015;203:1067-1072.
    PubMed     Text format     Abstract available


  336. KITAMURA M, Mimura Y, Taniue H, Yoshitake K, et al
    Predictors of independent walking at hospital discharge in elderly heart failure patients.
    Int J Cardiol. 2015;203:609-611.
    PubMed     Text format    


  337. KOEHLER U, Kesper K, Timmesfeld N, Grimm W, et al
    Cheyne-Stokes respiration in patients with heart failure.
    Int J Cardiol. 2015;203:775-778.
    PubMed     Text format    


  338. LOPATIN YM, Rosano GM, Fragasso G, Lopaschuk GD, et al
    Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
    Int J Cardiol. 2015;203:909-915.
    PubMed     Text format     Abstract available


  339. BROUWERS C, Christensen SB, Damen NL, Denollet J, et al
    Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression.
    Int J Cardiol. 2015;203:867-873.
    PubMed     Text format     Abstract available


    October 2015
  340. MESSIAS LR, Messias AC, de Miranda SM, Wiefels CC, et al
    Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction.
    Int J Cardiol. 2015;203:900-902.
    PubMed     Text format    


  341. MAYER O JR, Seidlerova J, Vanek J, Karnosova P, et al
    The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Int J Cardiol. 2015;203:916-922.
    PubMed     Text format     Abstract available


  342. BOWEN TS, Eisenkolb S, Werner S, Schwarzer M, et al
    Inheriting a high aerobic fitness predisposes to skeletal muscle and endothelial dysfunction in chronic heart failure.
    Int J Cardiol. 2015;203:353-356.
    PubMed     Text format    


  343. EYUBOGLU M
    Device therapy and aldosterone antagonists in the prognosis of heart failure.
    Int J Cardiol. 2015 Oct 28. pii: S0167-5273(15)30763.
    PubMed     Text format    


  344. KOTECHA D, Chudasama R, Lane DA, Kirchhof P, et al
    Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.
    Int J Cardiol. 2015;203:660-666.
    PubMed     Text format     Abstract available


  345. ROBLEK T, Deticek A, Leskovar B, Suskovic S, et al
    Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trial.
    Int J Cardiol. 2015;203:647-652.
    PubMed     Text format     Abstract available


  346. NYMO SH, Ueland T, Askevold E, Dahl CP, et al
    Circulating nucleosomes in chronic heart failure.
    Int J Cardiol. 2015;203:742-743.
    PubMed     Text format    


  347. YANG J, Fan Z, Yang J, Yang C, et al
    Relaxin: A novel therapy for acute heart failure.
    Int J Cardiol. 2015 Oct 27. pii: S0167-5273(15)30760.
    PubMed     Text format    


  348. GEMES K, Janszky I, Ahnve S, Laszlo KD, et al
    Light-to-moderate drinking and incident heart failure - the Norwegian HUNT study.
    Int J Cardiol. 2015;203:553-560.
    PubMed     Text format     Abstract available


  349. BARRA S, Providencia R, Agarwal S
    Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?
    Int J Cardiol. 2015;203:184-186.
    PubMed     Text format    


  350. HE WM, Luo YT, Shui X, Liao XX, et al
    Critical appraisal of international guidelines on chronic heart failure: Can China AGREE?
    Int J Cardiol. 2015;203:111-114.
    PubMed     Text format    


  351. BEHNES M, Bertsch T, Weiss C, Ahmad-Nejad P, et al
    Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
    Int J Cardiol. 2015;203:398-406.
    PubMed     Text format    


  352. FARMAKIS D, Stafylas P, Giamouzis G, Maniadakis N, et al
    The medical and socioeconomic burden of heart failure: A comparative delineation with cancer.
    Int J Cardiol. 2015;203:279-281.
    PubMed     Text format     Abstract available


  353. LOURENCO P, Ribeiro A, Cunha FM, Pintalhao M, et al
    Is there a heart rate paradox in acute heart failure?
    Int J Cardiol. 2015;203:409-414.
    PubMed     Text format    


  354. HAMMER F, Deutschbein T, Marx A, Guder G, et al
    High evening salivary cortisol is an independent predictor of increased mortality risk in patients with systolic heart failure.
    Int J Cardiol. 2015;203:69-73.
    PubMed     Text format     Abstract available


  355. CHEN Y, Huang W, Huang Y, Hu Y, et al
    Beta-blockers treatment in heart failure with atrial fibrillation - Who should we believe?
    Int J Cardiol. 2015;203:60-61.
    PubMed     Text format    


  356. MA H, Wang X, Xie H, Sun C, et al
    Characterization of the cardiac venous system in heart failure patients using 256-slice CT.
    Int J Cardiol. 2015;203:447-448.
    PubMed     Text format    


  357. LIN YS, Tung TH, Wang J, Chen YF, et al
    Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Int J Cardiol. 2015;203:204-211.
    PubMed     Text format     Abstract available


  358. GUVENC TS, Ekmekci A, Sargin M, Orhan G, et al
    Rapid improvement of pulmonary hemodynamics following combined tadalafil and inotropic treatment in a patient with pulmonary hypertension secondary to left ventricular dysfunction.
    Int J Cardiol. 2015;203:212-213.
    PubMed     Text format    


  359. ZACHARIAS M, Joffe S, Konadu E, Meyer T, et al
    Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients.
    Int J Cardiol. 2015;202:918-921.
    PubMed     Text format     Abstract available


  360. BIRGY C, Bresson D, Duculescu E, Carpentier M, et al
    Rare and life-threatening cardiovascular complication of chronic thromboembolic pulmonary hypertension diagnosed by trans-thoracic echocardiography.
    Int J Cardiol. 2015;203:450-452.
    PubMed     Text format    


  361. PETERS S
    Focal form of left ventricular non-compaction cardiomyopathy with congestive form of heart failure.
    Int J Cardiol. 2015;202:879.
    PubMed     Text format    


  362. ZENGIN E, Sinning C, Schrage B, Mueller GC, et al
    Right heart failure in pregnant women with cyanotic congenital heart disease - The good, the bad and the ugly.
    Int J Cardiol. 2015;202:773-775.
    PubMed     Text format    


  363. SHIRAISHI Y, Sawano M, Kohno T, Nishiyama T, et al
    Validation of the Seattle Heart Failure Model in Japanese heart failure patients.
    Int J Cardiol. 2015;203:87-89.
    PubMed     Text format    


  364. HOPPER I, Skiba M, Windebank E, Brack J, et al
    Polypharmacy in heart failure - Is reducing medication safe?
    Int J Cardiol. 2015 Oct 9. pii: S0167-5273(15)30533.
    PubMed     Text format    


  365. CHEN J, Stein S, Molina M, Owens A, et al
    Right heart size in orthotopic heart transplant population: Influence of donor and recipient gender, race, and body surface area.
    Int J Cardiol. 2015;203:105-106.
    PubMed     Text format    


    September 2015
  366. MIZUNO A, Ohde S, Hayashi A, Nakamura M, et al
    The differences of advance decision making between hospitalized patients with heart failure and malignant disease.
    Int J Cardiol. 2015;202:649-651.
    PubMed     Text format    


  367. HUANG Y, Huang W, Hu Y
    Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality?
    Int J Cardiol. 2015 Sep 27. pii: S0167-5273(15)30521.
    PubMed     Text format    


  368. VICENZI M, Deboeck G, Faoro V, Loison J, et al
    Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.
    Int J Cardiol. 2015;202:736-740.
    PubMed     Text format     Abstract available


  369. WANG J, Fang F, Yip GW, Sanderson JE, et al
    Importance of chronotropic response and left ventricular long-axis function for exercise performance in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2015;202:339-343.
    PubMed     Text format     Abstract available


  370. ALTER P, Koczulla AR, Nell C, Figiel JH, et al
    Wall stress determines systolic and diastolic function - Characteristics of heart failure.
    Int J Cardiol. 2015;202:685-693.
    PubMed     Text format     Abstract available


  371. ZHANG J, Hobkirk J, Carroll S, Pellicori P, et al
    Exploring quality of life in patients with and without heart failure.
    Int J Cardiol. 2015;202:676-684.
    PubMed     Text format     Abstract available


  372. LINDE C, Curtis AB, Fonarow GC, Lee K, et al
    Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Int J Cardiol. 2015;202:349-355.
    PubMed     Text format     Abstract available


  373. FANG F, Liu W, Zhao YX, Yang Y, et al
    The patient's selection of PARACHUTE(R) endoventricular partitioning device: The important role of detailed echocardiography.
    Int J Cardiol. 2015;195:176-9.
    PubMed     Text format    


  374. GIANNONI A, Raglianti V, Mirizzi G, Taddei C, et al
    Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure.
    Int J Cardiol. 2015;202:200-206.
    PubMed     Text format     Abstract available


  375. DHOBLE A, Kashif M, Chakravarty T, Jilaihawi H, et al
    Transcatheter tricuspid valve replacement along with tricuspid paravalvular leak closure in a patient with severe right heart failure and previous transcatheter pulmonary valve replacement.
    Int J Cardiol. 2015;202:198-199.
    PubMed     Text format    


  376. ROBLES-MEZCUA A, Gonzalez-Cruces N, Ruiz-Salas A, Morcillo-Hidalgo L, et al
    Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction.
    Int J Cardiol. 2015;202:118-120.
    PubMed     Text format    


  377. PAREEK M, Nielsen ML, Leosdottir M, Nilsson PM, et al
    Response to the letter by Tomoyuki Kawada: Diastolic function, fasting plasma glucose and left ventricular mass index.
    Int J Cardiol. 2015;194:58-9.
    PubMed     Text format    


    August 2015
  378. KELLER-ROSS ML, Johnson BD, Carter RE, Joyner MJ, et al
    Improved Ventilatory Efficiency with Locomotor Muscle Afferent Inhibition is Strongly Associated with Leg Composition in Heart Failure.
    Int J Cardiol. 2015;202:159-166.
    PubMed     Text format     Abstract available


  379. SILVETTI S, Nieminen MS
    Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
    Int J Cardiol. 2015;202:138-143.
    PubMed     Text format     Abstract available


  380. SPINAR J, Jarkovsky J, Spinarova L, Mebazaa A, et al
    AHEAD score - Long-term risk classification in acute heart failure.
    Int J Cardiol. 2015;202:21-26.
    PubMed     Text format     Abstract available


  381. MAGRI D, Banfi C, Maruotti A, Farina S, et al
    Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective study.
    Int J Cardiol. 2015;201:394-399.
    PubMed     Text format     Abstract available


  382. KAWADA T
    Diastolic function, fasting plasma glucose and left ventricular mass index.
    Int J Cardiol. 2015;193:58.
    PubMed     Text format    


  383. BUSSEY CT, Hughes G, Saxena P, Galvin IF, et al
    Chamber-specific changes in calcium-handling proteins in the type 2 diabetic human heart with preserved ejection fraction.
    Int J Cardiol. 2015;193:53-5.
    PubMed     Text format    


  384. VAN ITERSON EH, Snyder EM, Joyner MJ, Johnson BD, et al
    Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitance.
    Int J Cardiol. 2015;201:384-393.
    PubMed     Text format     Abstract available


  385. DOEHNER W, Jankowska EA, Springer J, Lainscak M, et al
    Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.
    Int J Cardiol. 2015 Aug 11. pii: S0167-5273(15)30319.
    PubMed     Text format     Abstract available


  386. WEIDMANN ZM, Breidthardt T, Twerenbold R, Zusli C, et al
    Prediction of mortality using quantification of renal function in acute heart failure.
    Int J Cardiol. 2015;201:650-657.
    PubMed     Text format     Abstract available


  387. MARU S, Byrnes J, Carrington MJ, Chan YK, et al
    Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Frien
    Int J Cardiol. 2015;201:368-375.
    PubMed     Text format     Abstract available


  388. FARMAKIS D, Parissis J, Karavidas A, Karvounis C, et al
    In-hospital management of acute heart failure: Practical recommendations and future perspectives.
    Int J Cardiol. 2015;201:231-236.
    PubMed     Text format     Abstract available


  389. KAJIMOTO K, Sato N, Takano T
    Relation between elevated blood urea nitrogen, clinical features or comorbidities, and clinical outcome in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2015;201:311-314.
    PubMed     Text format    


  390. LU Y, Zhang L, Zhou X, Tang B, et al
    Renal sympathetic denervation: A potential alternative strategy for managing patients with heart failure.
    Int J Cardiol. 2015;201:140-141.
    PubMed     Text format    


  391. GOTZ N, Patzelt J, Seizer P, Walker T, et al
    Percutaneous mitral valve repair (PMVR) in a patient with recurrence of mitral regurgitation 17years after surgical reconstruction.
    Int J Cardiol. 2015;201:321-323.
    PubMed     Text format    


  392. TAKAHASHI M, Kinugawa S, Takada S, Hirabayashi K, et al
    Low-intensity exercise under ischemic conditions enhances metabolic stress in patients with heart failure.
    Int J Cardiol. 2015;201:142-144.
    PubMed     Text format    


    July 2015
  393. TAKEUCHI T, Dohi K, Omori T, Moriwaki K, et al
    Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure.
    Int J Cardiol. 2015;201:1-3.
    PubMed     Text format    


  394. YAMAZOE M, Mizuno A, Niwa K, Isobe M, et al
    Edema index measured by bioelectrical impedance analysis as a predictor of fluid reduction needed to remove clinical congestion in acute heart failure.
    Int J Cardiol. 2015;201:190-192.
    PubMed     Text format    


  395. SAVARESE G, Edner M, Dahlstrom U, Perrone-Filardi P, et al
    Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2015;199:415-423.
    PubMed     Text format     Abstract available


  396. SMOLIS-BAK E, Dabrowski R, Piotrowicz E, Chwyczko T, et al
    Hospital-based and telemonitoring guided home-based training programs: Effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. A randomized, prospective observation.
    Int J Cardiol. 2015;199:442-447.
    PubMed     Text format     Abstract available


  397. PETERS S
    Prognostic value of epsilon waves in lead aVR in arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2015;191:77-8.
    PubMed     Text format    


  398. LAI KB, Sanderson JE, Izzat MB, Yu CM, et al
    Micro-RNA and mRNA myocardial tissue expression in biopsy specimen from patients with heart failure.
    Int J Cardiol. 2015;199:79-83.
    PubMed     Text format     Abstract available


  399. GAYAT E, Caillard A, Laribi S, Mueller C, et al
    Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure.
    Int J Cardiol. 2015;199:241-247.
    PubMed     Text format     Abstract available


  400. MASUDA M, Yamada T, Mizuno H, Minamiguchi H, et al
    Impact of atrial fibrillation ablation on cardiac sympathetic nervous system in patients with and without heart failure.
    Int J Cardiol. 2015;199:65-70.
    PubMed     Text format     Abstract available


  401. CHEN M, Yu L, Sheng X, Liu Q, et al
    Cardiac autonomic tone modulators: Promising feasible options for heart failure with hyper-sympathetic activity.
    Int J Cardiol. 2015;198:185-186.
    PubMed     Text format    


  402. ANTONIOU CK, Chrysohoou C, Lerakis S, Manolakou P, et al
    Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: A comparison of three therapeutic pr
    Int J Cardiol. 2015;199:44-49.
    PubMed     Text format     Abstract available


  403. DANDEL M, Krabatsch T, Falk V
    Left ventricular vs. biventricular mechanical support: Decision making and strategies for avoidance of right heart failure after left ventricular assist device implantation.
    Int J Cardiol. 2015;198:241-250.
    PubMed     Text format     Abstract available


    June 2015
  404. EYUBOGLU M
    How can we detect the low risk patients for ischemic etiology in heart failure population?
    Int J Cardiol. 2015;197:1.
    PubMed     Text format    


  405. WANG X, Peng J, Xie X, Qian J, et al
    Tricuspid regurgitation predicts cardiorenal syndrome in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2015;197:83-84.
    PubMed     Text format    


  406. RADEMAKER MT, Ellmers LJ, Charles CJ, Mark Richards A, et al
    Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine.
    Int J Cardiol. 2015;197:56-65.
    PubMed     Text format     Abstract available


  407. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".
    Int J Cardiol. 2015;189:247-8.
    PubMed     Text format    


  408. KRACHLER B, Savonen K, Komulainen P, Hassinen M, et al
    VO2max/kg is expected to be lower in obese individuals!
    Int J Cardiol. 2015;189:234.
    PubMed     Text format    


  409. RUSHTON CA, Satchithananda DK, Jones PW, Kadam UT, et al
    Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis.
    Int J Cardiol. 2015;196:98-106.
    PubMed     Text format     Abstract available


  410. FARAG M, Mabote T, Shoaib A, Zhang J, et al
    Hydralazine and nitrates alone or combined for the management of chronic heart failure: A systematic review.
    Int J Cardiol. 2015;196:61-69.
    PubMed     Text format     Abstract available


  411. TOPCU S, Aksu U, Tanboga IH, Sevimli S, et al
    Giant left ventricle pseudoaneurysm that caused heart failure.
    Int J Cardiol. 2015;196:34-35.
    PubMed     Text format    


  412. MAKINO J, Kohsaka S, Shiraishi Y, Inohara T, et al
    Application of the United States acute heart failure risk prediction model in Japanese patients; analysis from a contemporary multicenter registry.
    Int J Cardiol. 2015;195:323-325.
    PubMed     Text format    


    May 2015
  413. ALVELOS M, Couto M, Laszczynska O, Almeida PB, et al
    Measuring renal function in acute heart failure: A place for old and new equations.
    Int J Cardiol. 2015;196:70-72.
    PubMed     Text format    


  414. HELSEN F, De Meester P, Van Keer J, Gabriels C, et al
    Pulmonary outflow obstruction protects against heart failure in adults with congenitally corrected transposition of the great arteries.
    Int J Cardiol. 2015;196:1-6.
    PubMed     Text format     Abstract available


  415. LIM HS, Andrianopoulos N, Sugumar H, Stub D, et al
    Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.
    Int J Cardiol. 2015;195:259-264.
    PubMed     Text format     Abstract available


  416. VOLTERRANI M, Iellamo F
    Eplerenone in chronic heart failure with depressed systolic function.
    Int J Cardiol. 2015 May 21. pii: S0167-5273(15)01189.
    PubMed     Text format     Abstract available


  417. SCHOU M, Bosselmann H, Gaborit F, Iversen K, et al
    Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients.
    Int J Cardiol. 2015;195:143-148.
    PubMed     Text format     Abstract available


  418. MA Z, Fang F, Chui KL, Chen T, et al
    A Rare Etiology of Severe Acute Heart Failure: Subacute Spinal Subdural Hematoma in a Young Woman.
    Int J Cardiol. 2015;195:61-63.
    PubMed     Text format    


  419. FREA S, Bovolo V, Pidello S, Canavosio FG, et al
    Clinical and prognostic role of ammonia in advanced decompensated heart failure. The cardio-abdominal syndrome?
    Int J Cardiol. 2015;195:53-60.
    PubMed     Text format     Abstract available


  420. JAGODZINSKI A, Havulinna AS, Appelbaum S, Zeller T, et al
    Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Int J Cardiol. 2015;192:33-39.
    PubMed     Text format     Abstract available


  421. BRUNETTI ND, Correale M, Totaro A, Ferraretti A, et al
    Lower cardiovascular mortality with atorvastatin and rosuvastatin vs simvastatin: Data from "moderate-intensity" statin users in an observational registry on chronic heart failure (Daunia Heart Failure Registry).
    Int J Cardiol. 2015;194:23-27.
    PubMed     Text format    


  422. KATO S, Saito N, Kirigaya H, Gyotoku D, et al
    Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2015;191:314-319.
    PubMed     Text format     Abstract available


  423. KALUZA J, Akesson A, Wolk A
    Long-term processed and unprocessed red meat consumption and risk of heart failure: A prospective cohort study of women.
    Int J Cardiol. 2015;193:42-46.
    PubMed     Text format     Abstract available


  424. AKSU U, Topcu S
    Giant right atrium due to rheumatic tricuspid valve stenosis.
    Int J Cardiol. 2015;193:47-48.
    PubMed     Text format    


  425. AKSU U, Kalkan K
    Pericardial effusion and heart failure.
    Int J Cardiol. 2015;192:21.
    PubMed     Text format    


  426. NTALIANIS A, Kapelios CJ, Kanakakis J, Repasos E, et al
    Prolonged intra-aortic balloon pump support in biventricular heart failure induces right ventricular reverse remodeling.
    Int J Cardiol. 2015;192:3-8.
    PubMed     Text format     Abstract available


  427. SMEETS M, Degryse J, Aertgeerts B, Janssens S, et al
    General practitioners' judgement of chronic heart failure in the oldest old: Insights from the BELFRAIL study.
    Int J Cardiol. 2015;191:120-127.
    PubMed     Text format     Abstract available


  428. KAUFMANN BA, Goetschalckx K, Min SY, Maeder MT, et al
    Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy.
    Int J Cardiol. 2015;191:286-293.
    PubMed     Text format     Abstract available


  429. OH PC, Koh KK, Shin J, Yu J, et al
    Stress-induced cardiomyopathy presented with acute decompensated heart failure.
    Int J Cardiol. 2015;191:114-116.
    PubMed     Text format    


  430. KAJIMOTO K, Sato N, Takano T
    Association of age and baseline systolic blood pressure with outcomes in patients hospitalized for acute heart failure syndromes.
    Int J Cardiol. 2015;191:100-106.
    PubMed     Text format     Abstract available


  431. GUDER G, Stork S
    The role of circulatory power and cardiac reserve in reverse epidemiology - Assessing heart failure severity.
    Int J Cardiol. 2015;191:48-49.
    PubMed     Text format    


  432. SOUZA FC, Neri JS, Marques EB, Barros RB, et al
    Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
    Int J Cardiol. 2015;191:4-6.
    PubMed     Text format    


  433. NIEMINEN MS, Dickstein K, Fonseca C, Serrano JM, et al
    The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations.
    Int J Cardiol. 2015;191:256-264.
    PubMed     Text format     Abstract available


  434. KIRAT T, Kose N
    Response to the letter by Akinori Sairaku et al.: Different mechanisms = synergic effect.
    Int J Cardiol. 2015;186:148.
    PubMed     Text format    


    April 2015
  435. LUPON J, Barallat J, Bayes-Genis A
    Morbidity and mortality in systolic heart failure also associated with raised serum neprilysin levels. Reply.
    Int J Cardiol. 2015;190:201.
    PubMed     Text format    


  436. PARRAGH S, Hametner B, Bachler M, Kellermair J, et al
    Determinants and covariates of central pressures and wave reflections in systolic heart failure.
    Int J Cardiol. 2015;190:308-314.
    PubMed     Text format     Abstract available


  437. TAHIR U, Sam F
    Withdrawal of heart failure medications in peripartum cardiomyopathy after myocardial recovery.
    Int J Cardiol. 2015;190:212-213.
    PubMed     Text format    


  438. YAMAMOTO E, Hirata Y, Tokitsu T, Kusaka H, et al
    The pivotal role of eNOS uncoupling in vascular endothelial dysfunction in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2015;190:335-337.
    PubMed     Text format    


  439. PASTERNAK B, Mattsson A, Svanstrom H, Hviid A, et al
    Comparative effectiveness of bisoprolol and metoprolol succinate in patients with heart failure.
    Int J Cardiol. 2015;190:4-6.
    PubMed     Text format    


  440. BOOTH LC, Schlaich MP, Nishi EE, Yao ST, et al
    Short-term effects of catheter-based renal denervation on cardiac sympathetic drive and cardiac baroreflex function in heart failure.
    Int J Cardiol. 2015;190:220-226.
    PubMed     Text format     Abstract available


  441. SILVA F, Borges T, Ribeiro A, Mesquita R, et al
    Heart failure with reduced ejection fraction: Should we submit patients without angina to coronary angiography?
    Int J Cardiol. 2015;190:131-132.
    PubMed     Text format    


  442. THANG ND, Karlson BW, Sundstrom BW, Karlsson T, et al
    Pre-hospital prediction of death or cardiovascular complications during hospitalisation and death within one year in suspected acute coronary syndrome patients.
    Int J Cardiol. 2015;185:308-12.
    PubMed     Text format     Abstract available


  443. OHLOW MA, von Korn H, Lauer B
    Characteristics and outcome of congenital left ventricular aneurysm and diverticulum: Analysis of 809 cases published since 1816.
    Int J Cardiol. 2015;185:34-45.
    PubMed     Text format     Abstract available


  444. GRUSON D, Ferracin B, Ahn SA, Rousseau MF, et al
    Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients.
    Int J Cardiol. 2015;189:185-187.
    PubMed     Text format    


  445. QIAN F, Fonarow GC, Krim SR, Vivo RP, et al
    Characteristics, quality of care, and in-hospital outcomes of Asian-American heart failure patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program.
    Int J Cardiol. 2015;189:141-147.
    PubMed     Text format     Abstract available


  446. KATO T, Nakane E, Funasako M, Miyamoto S, et al
    A potential linkage between mitochondrial function of the heart and leg muscles in patients with heart failure.
    Int J Cardiol. 2015;188:67-69.
    PubMed     Text format    


  447. MARCULA M, de Souza Buto MF, Madaloso BA, Nunes RA, et al
    Lymphocyte count and prognosis in patients with heart failure.
    Int J Cardiol. 2015;188:60-62.
    PubMed     Text format    


  448. LIN GM, Li YH, Liu PY, Wu CF, et al
    Reverse epidemiology in patients with heart failure: The role of circulatory power and cardiac reserve.
    Int J Cardiol. 2015;188:54-55.
    PubMed     Text format    


  449. BAVISHI C, Khan AR, Ather S
    Digoxin in patients with atrial fibrillation and heart failure: A meta-analysis.
    Int J Cardiol. 2015;188:99-101.
    PubMed     Text format    


  450. FEOLA M, Testa M, Leto L, Rosso GL, et al
    The predictive value of non-invasive cardiac output at rest in discharged heart failure patients.
    Int J Cardiol. 2015;188:50-51.
    PubMed     Text format    


  451. GAO RJ, Zhou YH, Liu T, Han QF, et al
    Response to letter regarding "Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure".
    Int J Cardiol. 2015;187:434-435.
    PubMed     Text format    


  452. IYISOY A, Ozturk C, Unlu M, Celik T, et al
    Cardiac resynchronization therapy in a patient with percutaneous mitral annuloplasty and prior aortic valve surgery.
    Int J Cardiol. 2015;187:532-533.
    PubMed     Text format    


  453. HUANG B, Yu L, Zhou L, Jiang H, et al
    Renal denervation for the treatment of atrial fibrillation in hypertensive patients or beyond?
    Int J Cardiol. 2015;189:59-60.
    PubMed     Text format    


  454. GARNIER S, Hengstenberg C, Lamblin N, Dubourg O, et al
    Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: Results of a European collaboration assembling more than 2000 patients.
    Int J Cardiol. 2015;189:105-107.
    PubMed     Text format    


  455. LONG D, Xiao Y, Dong B, Zhou S, et al
    Being cast into the shade of beta blockers for concomitant heart failure and atrial fibrillation?
    Int J Cardiol. 2015;188:35.
    PubMed     Text format    


  456. BARYWANI SB, Ergatoudes C, Schaufelberger M, Petzold M, et al
    Does the target dose of neurohormonal blockade matter for outcome in Systolic heart failure in octogenarians?
    Int J Cardiol. 2015;187:666-672.
    PubMed     Text format     Abstract available


  457. WANG Z, Zhou X, Sheng X, Yu L, et al
    Noninvasive vagal nerve stimulation for heart failure: Was it practical or just a stunt?
    Int J Cardiol. 2015;187:637-638.
    PubMed     Text format    


  458. RAFIQ I, Freeman LJ
    Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'.
    Int J Cardiol. 2015;195:283-284.
    PubMed     Text format    


  459. YILDIZ A, Soydinc S
    Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
    Int J Cardiol. 2015;184:512-3.
    PubMed     Text format    


  460. MORETTI C, Grosso Marra W, D'Ascenzo F, Omede P, et al
    Beta blocker for patients with pulmonary arterial hypertension: A single center experience.
    Int J Cardiol. 2015;184:528-32.
    PubMed     Text format    


  461. PAREEK M, Nielsen ML, Gerke O, Leosdottir M, et al
    Worsening diastolic function is associated with elevated fasting plasma glucose and increased left ventricular mass in a supra-additive fashion in an elderly, healthy, Swedish population.
    Int J Cardiol. 2015;184:466-72.
    PubMed     Text format     Abstract available


  462. EINDHOVEN JA, Roos-Hesselink JW, van den Bosch AE, Kardys I, et al
    High-sensitive troponin-T in adult congenital heart disease.
    Int J Cardiol. 2015;184:405-11.
    PubMed     Text format     Abstract available


  463. OHUCHI H, Negishi J, Hayama Y, Sasaki O, et al
    Hyperuricemia reflects global Fontan pathophysiology and associates with morbidity and mortality in patients after the Fontan operation.
    Int J Cardiol. 2015;184:623-30.
    PubMed     Text format     Abstract available


  464. LUMENS J, Vernooy K
    Better understanding before implanting.
    Int J Cardiol. 2015;184:6-8.
    PubMed     Text format    


    March 2015
  465. APOSTOLO A, Laveneziana P, Palange P, Agalbato C, et al
    Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure.
    Int J Cardiol. 2015;189:134-140.
    PubMed     Text format     Abstract available


  466. LUPON J, Bayes-Genis A
    Answer. Reverse remodeling in systolic heart failure. The ST2-R2 score: a puzzle yet to be solved?
    Int J Cardiol. 2015;187:556.
    PubMed     Text format    


  467. ZABAROVSKAJA S, Hage C, Linde C, Daubert JC, et al
    Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Int J Cardiol. 2015;189:6-11.
    PubMed     Text format     Abstract available


  468. FERRERO P, Iacovoni A, D'Elia E, Vaduganathan M, et al
    Prognostic scores in heart failure - Critical appraisal and practical use.
    Int J Cardiol. 2015;188:1-9.
    PubMed     Text format     Abstract available


  469. ZHU Z, Hu X, Fang Z, Zhou S, et al
    Endothelial cell is critical in HMGB1 mediated cardiac impairment in ischemic heart disease.
    Int J Cardiol. 2015;187:39-40.
    PubMed     Text format    


  470. GAYDA M, Nigam A, Juneau M
    Letter regarding the article: Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls.
    Int J Cardiol. 2015;187:151.
    PubMed     Text format    


  471. CHRISTLE JW, Boscheri A, Pressler A, Grinninger C, et al
    Interval exercise training increases maximal and submaximal exercise performance in heart failure with biventricular assist device therapy.
    Int J Cardiol. 2015;187:104-105.
    PubMed     Text format    


  472. CORNELIS J, Taeymans J, Hens W, Beckers P, et al
    Response to letter to the editor: "Exercise oscillatory ventilation - Perfusion abnormality in heart failure".
    Int J Cardiol. 2015;187:103.
    PubMed     Text format    


  473. SIMANTIRAKIS EN, Nakou ES, Kallergis EM, Arkolaki EG, et al
    Long-term effect of If-channel inhibition on diastolic function and exercise capacity in heart failure patients with preserved ejection fraction.
    Int J Cardiol. 2015;187:9-11.
    PubMed     Text format    


  474. YAO HC, Li XY, Han QF, Wang LH, et al
    Elevated serum soluble ST2 levels may predict the fatal outcomes in patients with chronic heart failure.
    Int J Cardiol. 2015;186:303-304.
    PubMed     Text format    


  475. ZHOU H, Ni J, Yuan Y, Deng W, et al
    Soluble ST2 may possess special superiority as a risk predictor in heart failure patients.
    Int J Cardiol. 2015;186:146-147.
    PubMed     Text format    


  476. MA X, Sun F, Ma J
    Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.
    Int J Cardiol. 2015;187:387-388.
    PubMed     Text format    


  477. WHITE JM, Khalique OK, Kodali SK
    Immediate, same-setting paravalvular leak closure following transcatheter aortic valve replacement.
    Int J Cardiol. 2015;189:235-237.
    PubMed     Text format    


  478. JOLOBE OM
    Morbidity and mortality in systolic heart failure also associated with raised serum neprilysin levels.
    Int J Cardiol. 2015;187:234.
    PubMed     Text format    


  479. PICHOT V, Chouchou F, Pepin JL, Tamisier R, et al
    ECG-derived respiration: A promising tool for sleep-disordered breathing diagnosis in chronic heart failure patients.
    Int J Cardiol. 2015;186:7-9.
    PubMed     Text format    


  480. MALEK F, Neuzil P, Gustafsson F, Kaye DM, et al
    Clinical outcome of transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel implant.
    Int J Cardiol. 2015;187:227-228.
    PubMed     Text format    


  481. ROSSIGNOL P, Girerd N, Gregory D, Massaro J, et al
    Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study.
    Int J Cardiol. 2015;187:183-189.
    PubMed     Text format     Abstract available


  482. YALTA K
    Reverse remodelling in systolic heart failure: A puzzle yet to be solved?
    Int J Cardiol. 2015;187:46-47.
    PubMed     Text format    


  483. IZAWA KP, Watanabe S, Oka K, Tochimoto S, et al
    Longitudinal change in maximum phonation time and exercise capacity in chronic heart failure patients.
    Int J Cardiol. 2015;187:17-19.
    PubMed     Text format    


  484. QUTTAINAH M, Al-Hejailan R, Saleh S, Parhar R, et al
    Progression of matrixin and cardiokine expression patterns in an ovine model of heart failure and recovery.
    Int J Cardiol. 2015;186:77-89.
    PubMed     Text format     Abstract available


  485. YAP LB, Qadir F, Nguyen ST, Ma SK, et al
    The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients.
    Int J Cardiol. 2015;183:178-9.
    PubMed     Text format    


  486. KUSCHYK J, Roeger S, Schneider R, Streitner F, et al
    Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients.
    Int J Cardiol. 2015;183:76-81.
    PubMed     Text format     Abstract available


  487. BOONMAN-DE WINTER LJ, Hoes AW, Cramer MJ, de Jongh G, et al
    Prognosis of screen-detected heart failure with reduced and preserved ejection fraction in patients with type 2 diabetes.
    Int J Cardiol. 2015;185:162-164.
    PubMed     Text format    


  488. ADSETT JA, Mudge AM, Morris N, Kuys S, et al
    Aquatic exercise training and stable heart failure: A systematic review and meta-analysis.
    Int J Cardiol. 2015;186:22-28.
    PubMed     Text format     Abstract available


  489. KISAKA T, Rossiter HB, Wasserman K, Kihara Y, et al
    Exercise oscillatory ventilation: Ventilation-perfusion abnormality in heart failure.
    Int J Cardiol. 2015;185:55.
    PubMed     Text format    


  490. BARGE-CABALLERO E, Segovia-Cubero J, Gonzalez-Vilchez F, Delgado-Jimenez J, et al
    Evaluation of the preoperative vasoactive-inotropic score as a predictor of postoperative outcomes in patients undergoing heart transplantation.
    Int J Cardiol. 2015;185:192-194.
    PubMed     Text format    


  491. GEREDE DM, Sayin T, Vurgun VK, Akbulut IM, et al
    Dramatic improvement of clinical and hemodynamic parameters of a heart transplant candidate with sildenafil treatment.
    Int J Cardiol. 2015;185:148-149.
    PubMed     Text format    


  492. GAVAZZI A, De Maria R, Manzoli L, Bocconcelli P, et al
    Palliative needs for heart failure or chronic obstructive pulmonary disease: Results of a multicenter observational registry.
    Int J Cardiol. 2015;184:552-558.
    PubMed     Text format     Abstract available


  493. UDO EO, van Hemel NM, Zuithoff NP, Doevendans PA, et al
    Risk of heart failure- and cardiac death gradually increases with more right ventricular pacing.
    Int J Cardiol. 2015;185:95-100.
    PubMed     Text format     Abstract available


  494. CHANG S, Davidson PM, Newton PJ, Macdonald P, et al
    Composite outcome measures in a pragmatic clinical trial of chronic heart failure management: A comparative assessment.
    Int J Cardiol. 2015;185:62-68.
    PubMed     Text format     Abstract available


  495. KRUEGER K, Botermann L, Schorr SG, Griese-Mammen N, et al
    Age-related medication adherence in patients with chronic heart failure: A systematic literature review.
    Int J Cardiol. 2015;184:728-735.
    PubMed     Text format     Abstract available


  496. CIPRIANI M, Ammirati E, Landolina M, Oliva F, et al
    Cumulative analysis on 4802 patients confirming that women benefit more than men from cardiac resynchronization therapy.
    Int J Cardiol. 2015;182:454-6.
    PubMed     Text format    


  497. VON BIBRA H, Paulus WJ, St John Sutton M, Leclerque C, et al
    Quantification of diastolic dysfunction via the age dependence of diastolic function - impact of insulin resistance with and without type 2 diabetes.
    Int J Cardiol. 2015;182:368-74.
    PubMed     Text format     Abstract available


  498. BALLO P, Fantini A, Vannelli P, Fibbi V, et al
    A resynchronized shunt: Biventricular pacing followed by acute clinical decompensation in a patient with misdiagnosed atrial septal defect.
    Int J Cardiol. 2015;182:288-90.
    PubMed     Text format    


  499. LESZEK P, Sochanowicz B, Brzoska K, Danko B, et al
    Does myocardial iron load determine the severity of heart insufficiency?
    Int J Cardiol. 2015;182:191-3.
    PubMed     Text format    


  500. POPPE KK, Whalley GA, Doughty RN, Woodward M, et al
    The development and feasibility of a composite score of echocardiographic indices that may stratify outcome in patients with diabetes mellitus.
    Int J Cardiol. 2015;182:244-9.
    PubMed     Text format     Abstract available


    February 2015
  501. NAKAJIMA M, Takada A, Maeda H, Saito K, et al
    Near-miss of ruptured myocardial infarction and catheter ablation injury associated with lethal cardiac tamponade.
    Int J Cardiol. 2015;201:336-338.
    PubMed     Text format    


  502. BENDA NM, Eijsvogels TM, Van Dijk AP, Hopman MT, et al
    Changes in BNP and cardiac troponin I after high-intensity interval and endurance exercise in heart failure patients and healthy controls.
    Int J Cardiol. 2015;184C:426-427.
    PubMed     Text format    


  503. LIU T, Zhang Y, Zhou YH, Han QF, et al
    Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure.
    Int J Cardiol. 2015;184C:318-320.
    PubMed     Text format    


  504. CORRA U, Agostoni P, Piepoli MF
    Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure.
    Int J Cardiol. 2015;184C:299-301.
    PubMed     Text format    


  505. POURDJABBAR A, Dwivedi G, Haddad R, Saikali A, et al
    Heart rate control in patients with left ventricular systolic dysfunction and heart failure.
    Int J Cardiol. 2015;184C:276-277.
    PubMed     Text format    


  506. SANTAS E, Sandino J, Chorro FJ, Mendez J, et al
    Prognostic implications of pericardial effusion in acute heart failure: Does size matter?
    Int J Cardiol. 2015;184C:259-261.
    PubMed     Text format    


  507. ARCOPINTO M, Salzano A, Bossone E, Ferrara F, et al
    Multiple hormone deficiencies in chronic heart failure.
    Int J Cardiol. 2015;184C:421-423.
    PubMed     Text format    


  508. FINSTERER J, Stollberger C
    Primary prophylactic anticoagulation is mandatory if noncompaction is associated with atrial fibrillation or heart failure.
    Int J Cardiol. 2015;184C:268-269.
    PubMed     Text format    


  509. LUPON J, Gaggin HK, de Antonio M, Domingo M, et al
    Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.
    Int J Cardiol. 2015;184C:337-343.
    PubMed     Text format     Abstract available


  510. HOTHI SS, Tan DK, Partridge G, Tan LB, et al
    Is low V O/kg in obese heart failure patients indicative of cardiac dysfunction?
    Int J Cardiol. 2015;184:755-762.
    PubMed     Text format     Abstract available


  511. HELLENKAMP K, Darius H, Giannitsis E, Erbel R, et al
    The German CPU Registry: Dyspnea independently predicts negative short-term outcome in patients admitted to German Chest Pain Units.
    Int J Cardiol. 2015;181:88-95.
    PubMed     Text format     Abstract available


  512. GUDER G, Gelbrich G, Edelmann F, Wachter R, et al
    Reverse epidemiology in different stages of heart failure.
    Int J Cardiol. 2015;184C:216-224.
    PubMed     Text format     Abstract available


  513. FORD I, Robertson M, Komajda M, Bohm M, et al
    Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model.
    Int J Cardiol. 2015;184C:163-169.
    PubMed     Text format     Abstract available


  514. FINEGOLD J, Bordachar P, Kyriacou A, Sohaib SM, et al
    Atrioventricular delay optimization of cardiac resynchronisation therapy: comparison of non-invasive blood pressure with invasive haemodynamic measures.
    Int J Cardiol. 2015;180:221-2.
    PubMed     Text format    


    January 2015
  515. BIAN Y, Xu F, Lv RJ, Wang JL, et al
    An early warning scoring system for the prevention of acute heart failure.
    Int J Cardiol. 2015;183C:111-116.
    PubMed     Text format     Abstract available


  516. GRECO C, Rosato S, D'Errigo P, Mureddu GF, et al
    Trends in mortality and heart failure after acute myocardial infarction in Italy from 2001 to 2011.
    Int J Cardiol. 2015;184C:115-121.
    PubMed     Text format     Abstract available


  517. YAP J, Sim D, Lim CP, Chia SY, et al
    Predictors of two-year mortality in Asian patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2015;183C:33-38.
    PubMed     Text format     Abstract available


  518. REPASOS E, Kaldara E, Ntalianis A, Pantsios C, et al
    Intermittent renal replacement therapy for end stage drug refractory heart failure.
    Int J Cardiol. 2015;183C:24-26.
    PubMed     Text format    


  519. JIN Q, Jacobsen PK, Pehrson S, Chen X, et al
    Acute and long term outcomes of catheter ablation using remote magnetic navigation for the treatment of electrical storm in patients with severe ischemic heart failure.
    Int J Cardiol. 2015;183C:11-16.
    PubMed     Text format     Abstract available


  520. LATTUCA B, Roubille F
    Ivabradine: a promising drug in cardiogenic shock to prevent the undesirable sinus tachycardia induced by dobutamine?
    Int J Cardiol. 2015;178:308-10.
    PubMed     Text format    


  521. SHIUE I, Perkins DR, Bearman N
    Postprocedural disorders of circulatory system admissions peaked at physically equivalent temperature 0-10 degrees C in Germany in 2009-2011.
    Int J Cardiol. 2015;178:10-1.
    PubMed     Text format    


  522. CORNELIS J, Taeymans J, Hens W, Beckers P, et al
    Prognostic respiratory parameters in heart failure patients with and without exercise oscillatory ventilation - A systematic review and descriptive meta-analysis.
    Int J Cardiol. 2015;182C:476-486.
    PubMed     Text format     Abstract available


  523. LANCELLOTTI P, Ancion A, Magne J, Ferro G, et al
    Elevated heart rate at 24-36h after admission and in-hospital mortality in acute in non-arrhythmic heart failure.
    Int J Cardiol. 2015;182C:426-430.
    PubMed     Text format     Abstract available


  524. MONTERO-PEREZ-BARQUERO M, Manzano L, Formiga F, Roughton M, et al
    Utility of the SENIORS elderly heart failure risk model applied to the RICA registry of acute heart failure.
    Int J Cardiol. 2015;182C:449-453.
    PubMed     Text format     Abstract available


  525. SMART NA, Jeffriess L, Giallauria F, Vigorito C, et al
    Effect of duration of data averaging interval on reported peak VO in patients with heart failure.
    Int J Cardiol. 2015;182C:530-533.
    PubMed     Text format     Abstract available


  526. RIGGER J, Ehl NF, Nagele R, Rickli H, et al
    Giant biventricular thrombi in a patient with heart failure and heparin-induced thrombocytopenia.
    Int J Cardiol. 2015;182C:377-378.
    PubMed     Text format    


  527. WANG BH, von Lueder TG, Kompa AR, Huang L, et al
    Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.
    Int J Cardiol. 2015;186:104-5.
    PubMed     Text format    


  528. NAPP LC, Brehm M, Kuhn C, Schafer A, et al
    Heart against veno-arterial ECMO: Competition visualized.
    Int J Cardiol. 2015;187:164-5.
    PubMed     Text format    


  529. RODRIGUEZ Y, Nan J, Yasin O, Gorcsan J 3rd, et al
    The impact of a strategy of image-guided left ventricular lead placement during cardiac resynchronization therapy on health care utilization.
    Int J Cardiol. 2015;187:311-2.
    PubMed     Text format    


  530. TAN DK, Hothi SS, Macdonald W, Schlosshan D, et al
    Impacts of valve intervention on the Functional REServe of the Heart: The FRESH-valve pilot study.
    Int J Cardiol. 2015;187:491-501.
    PubMed     Text format     Abstract available


    December 2014
  531. KOYAMA T, Watanabe H, Ito H
    Nocturnal effects of diurnal adaptive servo-ventilation therapy in patients with heart failure.
    Int J Cardiol. 2014;182C:216-218.
    PubMed     Text format    


  532. PHAN K, Mitchell P, Liew G, Plant AJ, et al
    Relationship between macular degeneration with prevalent heart failure: A cross-sectional population study.
    Int J Cardiol. 2014;182C:213-215.
    PubMed     Text format    


  533. IZAWA KP, Watanabe S, Oka K, Brubaker PH, et al
    Differences in maximum phonation time based on body mass index in chronic heart failure patients.
    Int J Cardiol. 2014;182C:200-202.
    PubMed     Text format    


  534. AL-MAJED NS, Armstrong PW, Bakal JA, Hernandez AF, et al
    Correlation between peak expiratory flow rate and NT-proBNP in patients with acute heart failure. An analysis from ASCEND-HF trial.
    Int J Cardiol. 2014;182C:184-186.
    PubMed     Text format    


  535. CHEN A, Hou W, Zhang Y, Chen Y, et al
    Prognostic value of serum galectin-3 in patients with heart failure: A meta-analysis.
    Int J Cardiol. 2014;182C:168-170.
    PubMed     Text format    


  536. RAFOULI-STERGIOU P, Parissis J, Farmakis D, Bistola V, et al
    Prognostic value of in-hospital change in cystatin C in patients with acutely decompensated heart failure and renal dysfunction.
    Int J Cardiol. 2014;182C:74-76.
    PubMed     Text format    


  537. WAN H, Yang Y, Zhu J, Wang J, et al
    Prognostic value of ventricular heart rate in patients with permanent atrial fibrillation and heart failure.
    Int J Cardiol. 2014;182C:70-71.
    PubMed     Text format    


  538. VAN LAAK V, Dreysse S, Fleck E, Gebker R, et al
    An unusual cause of right heart failure.
    Int J Cardiol. 2014;182C:457-458.
    PubMed     Text format    


  539. SVANSTROM H, Pasternak B, Melbye M, Hviid A, et al
    Use of different types of angiotensin converting enzyme inhibitors and mortality in systolic heart failure.
    Int J Cardiol. 2014;182C:90-96.
    PubMed     Text format     Abstract available


  540. WAN Y, Xhang X, Atherton JJ, Kostner K, et al
    A multimarker approach to diagnose and stratify heart failure.
    Int J Cardiol. 2014;181C:369-375.
    PubMed     Text format     Abstract available


  541. RIGOLLI M, Rossi A, Quintana M, Klein AL, et al
    The prognostic impact of diastolic dysfunction in patients with chronic heart failure and post-acute myocardial infarction: Can age-stratified E/A ratio alone predict survival?
    Int J Cardiol. 2014;181C:362-368.
    PubMed     Text format     Abstract available


  542. MERT KU, Mert GO, Basaran O, Biteker M, et al
    Does ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: Parallax in significance.
    Int J Cardiol. 2014;177:726.
    PubMed     Text format    


  543. LAZZERI C, Valente S, Chiostri M, D'Alfonso MG, et al
    Prognostic impact of early glucose variability in acute heart failure patients: A pilot study.
    Int J Cardiol. 2014;177:693-5.
    PubMed     Text format    


  544. XU J, Bu L, Huang L, Yang Y, et al
    Heart failure having little effect on the progression of Parkinson's disease: Direct evidence from mouse model.
    Int J Cardiol. 2014;177:683-9.
    PubMed     Text format    


  545. WANG Z, Yu L, Chen M, Wang S, et al
    Transcutaneous electrical stimulation of auricular branch of vagus nerve: A noninvasive therapeutic approach for post-ischemic heart failure.
    Int J Cardiol. 2014;177:676-7.
    PubMed     Text format    


  546. NASSIF ME, Novak E, Rich MW
    Association of serum bicarbonate with long-term outcomes in patients hospitalized with heart failure.
    Int J Cardiol. 2014;177:673-5.
    PubMed     Text format    


  547. IZAWA KP, Watanabe S, Oka K, Brubaker PH, et al
    Leisure-time physical activity over four seasons in chronic heart failure patients.
    Int J Cardiol. 2014;177:651-3.
    PubMed     Text format    


  548. YANG C, Chen A, Chen R, Qi Y, et al
    Acute effect of ambient air pollution on heart failure in Guangzhou, China.
    Int J Cardiol. 2014;177:436-41.
    PubMed     Text format     Abstract available


  549. KORANTZOPOULOS P
    Maneuvers to eliminate loss of biventricular pacing due to T-wave oversensing.
    Int J Cardiol. 2014;177:523.
    PubMed     Text format    


  550. FARRE N, Aranyo J, Enjuanes C, Verdu-Rotellar JM, et al
    Differences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activation.
    Int J Cardiol. 2014;181C:120-126.
    PubMed     Text format     Abstract available


  551. CORRAO G, Ghirardi A, Ibrahim B, Merlino L, et al
    Short- and long-term mortality and hospital readmissions among patients with new hospitalization for heart failure: A population-based investigation from Italy.
    Int J Cardiol. 2014;181C:81-87.
    PubMed     Text format     Abstract available


    November 2014
  552. PANOULAS VF, Montorfano M, Contri R, Spagnolo P, et al
    Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation.
    Int J Cardiol. 2014;180C:199-202.
    PubMed     Text format    


  553. PARISSIS J, Athanasakis K, Farmakis D, Boubouchairopoulou N, et al
    Determinants of the direct cost of heart failure hospitalization in a public tertiary hospital.
    Int J Cardiol. 2014;180C:46-49.
    PubMed     Text format     Abstract available


  554. KANEKO H, Suzuki S, Goto M, Yuzawa Y, et al
    Geriatric nutritional risk index in hospitalized heart failure patients.
    Int J Cardiol. 2014;181C:213-215.
    PubMed     Text format    


  555. GREVE AM, Bang CN, Berg RM, Egstrup K, et al
    Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: The SEAS study.
    Int J Cardiol. 2014;180C:122-128.
    PubMed     Text format     Abstract available


  556. SAIRAKU A, Nakano Y, Kihara Y
    Increased urine output by ipragliflozin in a non-diabetic patient with a diuretic-resistant heart failure.
    Int J Cardiol. 2014;180C:42-43.
    PubMed     Text format    


  557. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Int J Cardiol. 2014;180C:1-5.
    PubMed     Text format     Abstract available


  558. WHITE M, Patel K, Caldentey G, Deedwania P, et al
    Racial differences in mortality in patients with advanced systolic heart failure: Potential role of right ventricular ejection fraction.
    Int J Cardiol. 2014;177:255-260.
    PubMed     Text format     Abstract available


  559. ROZENTRYT P, Nowak J, Niedziela J, Hudzik B, et al
    Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy.
    Int J Cardiol. 2014;177:248-254.
    PubMed     Text format     Abstract available


  560. CIOFFI G, Pulignano G, Barbati G, Tarantini L, et al
    Reasons why patients suffering from chronic heart failure at very high risk for death survive.
    Int J Cardiol. 2014;177:213-218.
    PubMed     Text format     Abstract available


  561. CUBA-GYLLENSTEN I, Gastelurrutia P, Riistama J, Aarts R, et al
    A novel wearable vest for tracking pulmonary congestion in acutely decompensated heart failure.
    Int J Cardiol. 2014;177:199-201.
    PubMed     Text format    


  562. ZAMORA E, Lupon J, de Antonio M, Galan A, et al
    Renal function largely influences Galectin-3 prognostic value in heart failure.
    Int J Cardiol. 2014;177:171-177.
    PubMed     Text format     Abstract available


  563. MIRANDA SM, Moscavitch SD, Pereira SB, de Azevedo JC, et al
    Heart failure patients with B1-adrenoreceptor polymorphisms have augmented carvedilol response as detected by cardiac I123-MIBG scintigraphy.
    Int J Cardiol. 2014;177:111-113.
    PubMed     Text format    


  564. WANG KL, Liu CJ, Chao TF, Huang CM, et al
    Sitagliptin and the risk of hospitalization for heart failure: A population-based study.
    Int J Cardiol. 2014;177:86-90.
    PubMed     Text format     Abstract available


  565. TU T, Xiao Y, Zhou S, Liu Q, et al
    Renal denervation: One potential therapeutic target for comorbid diabetes mellitus and worsening heart failure.
    Int J Cardiol. 2014;177:37-38.
    PubMed     Text format    


  566. ABBATE A, Arena R, Abouzaki N, Van Tassell BW, et al
    Heart failure with preserved ejection fraction: Refocusing on diastole.
    Int J Cardiol. 2014 Nov 14. pii: S0167-5273(14)02267.
    PubMed     Text format     Abstract available


  567. PIPER SE, Sherwood RA, Amin-Youssef GF, Shah AM, et al
    Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.
    Int J Cardiol. 2014;178C:284-291.
    PubMed     Text format     Abstract available


  568. COSTANZA AC, Moscavitch SD, Faria Neto HC, Mesquita ET, et al
    Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial.
    Int J Cardiol. 2014;179C:348-350.
    PubMed     Text format    


  569. SOUZA FC, Baptista TM, Marques EB, Barros RB, et al
    Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure.
    Int J Cardiol. 2014;179C:343-344.
    PubMed     Text format    


  570. WANG R, Cao Z, Li Y, Yu K, et al
    Mean platelet volume provides an additive value in differentiating congestive heart failure from chronic obstructive pulmonary disease.
    Int J Cardiol. 2014;179C:201-202.
    PubMed     Text format    


  571. DAS D, Bakal JA, Westerhout CM, Hernandez AF, et al
    The association between meteorological events and acute heart failure: New insights from ASCEND-HF.
    Int J Cardiol. 2014;177:819-824.
    PubMed     Text format     Abstract available


  572. SHAO Q, Li L, Li G, Liu T, et al
    Prognostic value of red blood cell distribution width in heart failure patients: A meta-analysis.
    Int J Cardiol. 2014 Nov 6. pii: S0167-5273(14)02184.
    PubMed     Text format    


  573. BODEY F, Hopper I, Krum H
    Neprilysin inhibitors preserve renal function in heart failure.
    Int J Cardiol. 2014;179C:329-330.
    PubMed     Text format    


  574. CHRYSOHOOU C, Angelis A, Tsitsinakis G, Spetsioti S, et al
    Cardiovascular effects of high-intensity interval aerobic training combined with strength exercise in patients with chronic heart failure. A randomized phase III clinical trial.
    Int J Cardiol. 2014;179C:269-274.
    PubMed     Text format     Abstract available


  575. GALLET R, Ternacle J, Lim P
    Response to letter: "Does Ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: Parallax in significance"
    Int J Cardiol. 2014;179C:217.
    PubMed     Text format    


  576. TAKEUCHI T, Dohi K, Kumagai N, Nakamori S, et al
    Effects of cardiac resynchronization therapy on left ventricular mechanical dyssynchrony induced by right ventricular pacing in a patient with heart failure and preserved ejection fraction.
    Int J Cardiol. 2014;177:1069-1072.
    PubMed     Text format    


  577. ROSSIGNOL P, Zannad F, Pitt B
    Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: Lessons from randomized controlled trials and registries.
    Int J Cardiol. 2014;177:731-733.
    PubMed     Text format     Abstract available


  578. BROCH K, Andreassen AK, Ueland T, Michelsen AE, et al
    Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure.
    Int J Cardiol. 2014;179C:378-384.
    PubMed     Text format     Abstract available


  579. HIRATA Y, Yamamoto E, Tokitsu T, Kusaka H, et al
    Reactive oxidative metabolites are associated with the severity of heart failure and predict future cardiovascular events in heart failure with preserved left ventricular ejection fraction.
    Int J Cardiol. 2014;179C:305-308.
    PubMed     Text format    


  580. VAN DIEPEN S, Podder M, Hernandez AF, Westerhout CM, et al
    Acute decompensated heart failure patients admitted to critical care units: Insights from ASCEND-HF.
    Int J Cardiol. 2014;177:840-846.
    PubMed     Text format     Abstract available


    October 2014
  581. KASAMA S, Toyama T, Kurabayashi M
    Serial I-metaiodobenzylguanidine imaging predicts the risk of sudden cardiac death in patients with chronic heart failure.
    Int J Cardiol. 2014;179C:82-83.
    PubMed     Text format    


  582. YAMAGUCHI T, Izumi Y, Nakamura Y, Yamazaki T, et al
    Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction.
    Int J Cardiol. 2014;178C:239-246.
    PubMed     Text format     Abstract available


  583. MOLLER-HELGESTAD OK, Poulsen CB, Christiansen EH, Lassen JF, et al
    Support with intra-aortic balloon pump vs. Impella2.5(R) and blood flow to the heart, brain and kidneys - An experimental porcine model of ischaemic heart failure.
    Int J Cardiol. 2014;178C:153-158.
    PubMed     Text format     Abstract available


  584. WANG J, Wu X, Hu X, Jiang H, et al
    Selectively inhibiting PDE5: A novel therapeutic target for reversing cardiac remodeling in heart failure.
    Int J Cardiol. 2014;178C:210-211.
    PubMed     Text format    


  585. WANG J, Fang F, Wai-Kwok Yip G, Sanderson JE, et al
    Left ventricular long-axis performance during exercise is an important prognosticator in patients with heart failure and preserved ejection fraction.
    Int J Cardiol. 2014;178C:131-135.
    PubMed     Text format     Abstract available


  586. PERRONE-FILARDI P, Savarese G, Scarano M, Cavazzina R, et al
    Prognostic impact of metabolic syndrome in patients with chronic heart failure: Data from GISSI-HF trial.
    Int J Cardiol. 2014;178C:85-90.
    PubMed     Text format     Abstract available


  587. WITMAN MA, Ives SJ, Trinity JD, Groot HJ, et al
    Heart failure and movement-induced hemodynamics: Partitioning the impact of central and peripheral dysfunction.
    Int J Cardiol. 2014;178C:232-238.
    PubMed     Text format     Abstract available


  588. AMPADU J, Morley JE
    Heart failure and cognitive dysfunction.
    Int J Cardiol. 2014;178C:12-23.
    PubMed     Text format     Abstract available


  589. ABUHAB A, Bacal F
    Cost-effectiveness analysis of Chagas' cardiomyopathy: early diagnosis and prevention should be the target for comparison.
    Int J Cardiol. 2014;176:1238.
    PubMed     Text format    


  590. RITT LE, Myers J, Stein R, Arena R, et al
    Additive prognostic value of a cardiopulmonary exercise test score in patients with heart failure and intermediate risk.
    Int J Cardiol. 2014;178C:262-264.
    PubMed     Text format    


  591. SHAFFER JA, Thompson JL, Cheng B, Ye S, et al
    Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial.
    Int J Cardiol. 2014;177:715-717.
    PubMed     Text format    


  592. PEREZ-FLORES G, Castillo-Martinez L, Orea-Tejeda A, Keirns-Davis C, et al
    Frequency and clinical characteristics of acute heart failure patients at INCMNSZ, Mexico City, Mexico.
    Int J Cardiol. 2014;177:1085-1086.
    PubMed     Text format    


  593. BOSSELMANN H, Tonder N, Soletormos G, Rossing K, et al
    Influence of renal impairment on myocardial function in outpatients with systolic heart failure: An echocardiographic and cardiac biomarker study.
    Int J Cardiol. 2014;177:942-948.
    PubMed     Text format     Abstract available


  594. JAMES S, Barton D, O'Connell E, Voon V, et al
    Life expectancy for community-based patients with heart failure from time of diagnosis.
    Int J Cardiol. 2014;178C:268-274.
    PubMed     Text format     Abstract available


    August 2014
  595. NAIR N, Gupta S, Collier IX, Gongora E, et al
    Can microRNAs emerge as biomarkers in distinguishing HFpEF versus HFrEF?
    Int J Cardiol. 2014;175:395-9.
    PubMed     Text format     Abstract available


  596. SINGHAL R, Chang SL, Chong E, Hsiao YW, et al
    Colchicine suppresses atrial fibrillation in failing heart.
    Int J Cardiol. 2014 Aug 17. pii: S0167-5273(14)01277.
    PubMed     Text format     Abstract available


  597. GIALLAURIA F, Vigorito C, Piepoli MF, Stewart Coats AJ, et al
    Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials.
    Int J Cardiol. 2014;175:352-7.
    PubMed     Text format     Abstract available


    July 2014
  598. JENEI ZM, Forhecz Z, Gombos T, Pozsonyi Z, et al
    Red cell distribution width as predictive marker in CHF: testing of model performance by reclassification methods.
    Int J Cardiol. 2014;174:783-5.
    PubMed     Text format    


    May 2014
  599. AKERSTROM F, Pachon M, Puchol A, Jimenez-Lopez J, et al
    Chronic right ventricular apical pacing: adverse effects and current therapeutic strategies to minimize them.
    Int J Cardiol. 2014;173:351-60.
    PubMed     Text format     Abstract available


  600. LAZZERI C, Chiostri M, D'Alfonso MG, Passantino S, et al
    Predictors of early mortality in acute cardiac patients requiring renal replacement therapy: a single center experience.
    Int J Cardiol. 2014;173:535-6.
    PubMed     Text format    


  601. AQUARO GD, Del Franco A, Meini M, Gabutti A, et al
    Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users.
    Int J Cardiol. 2014;173:614-5.
    PubMed     Text format    


  602. MOLNAR Z, Vincent JL
    Still a (valuable) place for the pulmonary artery catheter.
    Int J Cardiol. 2014;173:131-2.
    PubMed     Text format    


    April 2014
  603. KOZA Y
    Uric acid elevation in atrial fibrillation: Is it simply an epiphenomenon or not?
    Int J Cardiol. 2014 Apr 25. pii: S0167-5273(14)00897.
    PubMed     Text format    


  604. KOLANOWSKI TJ, Rozwadowska N, Malcher A, Szymczyk E, et al
    In vitro and in vivo characteristics of connexin 43-modified human skeletal myoblasts as candidates for prospective stem cell therapy for the failing heart.
    Int J Cardiol. 2014;173:55-64.
    PubMed     Text format     Abstract available


  605. POURRAJAB F, Babaei Zarch M, Baghi Yazdi M, Rahimi Zarchi A, et al
    Application of stem cell/growth factor system, as a multimodal therapy approach in regenerative medicine to improve cell therapy yields.
    Int J Cardiol. 2014;173:12-9.
    PubMed     Text format     Abstract available


  606. DENG W, Wei L, Zong J, Bian Z, et al
    Attenuation of cardiac remodeling by indole-3-carbinol in mice is associated with improved energy metabolism.
    Int J Cardiol. 2014;172:e531-3.
    PubMed     Text format    


  607. KAWATA H, Patel J, McGarry T, Joshi R, et al
    Obese female patients have higher rates of lead dislodgement after ICD or CRT-D implantation.
    Int J Cardiol. 2014;172:e522-4.
    PubMed     Text format    


    March 2014
  608. RUITER G, van de Veerdonk MC, Bogaard HJ, Wong YY, et al
    The interventricular septum in pulmonary hypertension does not show features of right ventricular failure.
    Int J Cardiol. 2014 Mar 18. pii: S0167-5273(14)00489.
    PubMed     Text format    


  609. FRIGERIO M, Lunati M, Pasqualucci D, Vargiu S, et al
    Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience.
    Int J Cardiol. 2014;172:64-71.
    PubMed     Text format     Abstract available


  610. GUPTA S, Figueredo VM
    Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management.
    Int J Cardiol. 2014;172:40-6.
    PubMed     Text format     Abstract available


  611. SAUER AJ, Selvaraj S, Aguilar FG, Martinez EE, et al
    Relationship between repolarization heterogeneity and abnormal myocardial mechanics.
    Int J Cardiol. 2014;172:289-91.
    PubMed     Text format    


  612. STOLLBERGER C, Streit N, Yoshida T, Wegner C, et al
    Left ventricular hypertrabeculation/noncompaction and pregnancy.
    Int J Cardiol. 2014;172:271-3.
    PubMed     Text format    


    February 2014
  613. YANG YM, Shao XH, Zhu J, Zhang H, et al
    Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: A national wide database analysis.
    Int J Cardiol. 2014 Feb 28. pii: S0167-5273(14)00395.
    PubMed     Text format     Abstract available


    January 2014
  614. FUKASAWA Y, Tanno J, Nakano S, Kimura F, et al
    Hemodynamic decompensation caused by acute myocardial infarction in an adult with Ebstein's anomaly.
    Int J Cardiol. 2014 Jan 11. pii: S0167-5273(14)00180.
    PubMed     Text format    


  615. AL-KHATIB SM, Han JY, Edwards R, Bardy GH, et al
    Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?
    Int J Cardiol. 2014 Jan 10. pii: S0167-5273(14)00153.
    PubMed     Text format    


  616. YEO I, Park Y, Moreno J, Ezigbo C, et al
    Cardiovascular manifestation of influenza in isolated ventricular noncompaction: another reason to vaccinate.
    Int J Cardiol. 2014;172:e201-2.
    PubMed     Text format    


    July 2013
  617. MENOTTI A , Puddu PE, Lanti M, Kromhout D, et al
    Epidemiology of typical coronary heart disease versus heart disease of uncertain etiology (atypical) fatalities and their relationships with classic coronary risk factors.
    Int J Cardiol. 2013 Jul 25. pii: S0167-5273(13)01229.
    PubMed     Text format     Abstract available


  618. CHANG SL , Chen YC, Hsu CP, Kao YH, et al
    Heat shock protein inducer modifies arrhythmogenic substrate and inhibits atrial fibrillation in the failing heart.
    Int J Cardiol. 2013 Jul 19. pii: S0167-5273(13)01127.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: